<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PEN</journal-id>
<journal-id journal-id-type="hwp">sppen</journal-id>
<journal-id journal-id-type="nlm-ta">JPEN J Parenter Enteral Nutr</journal-id>
<journal-title>Journal of Parenteral and Enteral Nutrition</journal-title>
<issn pub-type="ppub">0148-6071</issn>
<issn pub-type="epub">1941-2444</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0148607111416485</article-id>
<article-id pub-id-type="publisher-id">10.1177_0148607111416485</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Communications</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Do Dietary Supplements Have Beneficial Health Effects in Industrialized Nations</article-title>
<subtitle>What Is the Evidence?</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Marik</surname><given-names>Paul E.</given-names></name>
<degrees>MD, FCCP, FCCM, FACP, ABPNS</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Flemmer</surname><given-names>Mark</given-names></name>
<degrees>MBBCh, FCP(SA)</degrees>
</contrib>
<aff id="aff1-0148607111416485">Department of Medicine and the Nutrition Study Group, Eastern Virginia Medical School, Norfolk, Virginia, USA</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-0148607111416485">Paul E. Marik, MD, FCCP, FCCM, FACP, ABPNS, Department of Medicine and the Nutrition Study Group, Eastern Virginia Medical School, 825 Fairfax Ave, Suite 410, Norfolk, VA 23507, USA; e-mail: <email>marikpe@evms.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2012</year>
</pub-date>
<volume>36</volume>
<issue>2</issue>
<fpage>159</fpage>
<lpage>168</lpage>
<permissions>
<copyright-statement>© 2012 The American Society for Parenteral and Enteral Nutrition</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">The American Society for Parenteral and Enteral Nutrition</copyright-holder>
</permissions>
<abstract>
<p><italic>Background</italic>: Dietary supplements are regularly used by at least half of the American population, yet the health benefits of these agents are unclear. Objective: A systematic review to determine the benefits and risks of dietary supplements in Westernized societies. <italic>Data Sources</italic>: MEDLINE, Embase, Cochrane Register of Controlled Trials and citation review of relevant articles. <italic>Study Selection</italic>: Randomized, placebo-controlled clinical trials in non-pregnant Westernized adults that evaluated clinical outcomes of nutritional supplements. <italic>Data Extraction</italic>: Data were abstracted on study design, study size, study setting, patient population, dietary intervention and clinical outcomes. The outcome of each study was classified as non-beneficial, beneficial or harmful according to whether theend-point(s) of interest reached statistical significance. <italic>Data Synthesis</italic>: Sixty-three studies met the criteria for our systematic review. No benefit was recorded in 45 studies, with 10 of these showing a trend towards harm and with two showing a trend towards benefit. Four studies reported harm with increased cancer deaths (n=2) and increased fractures (n=2). Two studies reported both a harmful as well as a beneficial outcome. A beneficial outcome was reported in 12 studies; 6 which studied vitamin D and three which investigated omega-3 fatty acids. While a benefit was reported in one study each which investigated Vitamin E, folic acid and <italic>Ginkgo biloba</italic> this benefit was not confirmed by larger and more adequately powered studies. <italic>Conclusions</italic>: With the possible exceptions of Vitamin D and omega-3 fatty acids there is no data to support the widespread use of dietary supplements in Westernized populations; indeed, many of these supplements may be harmful.</p>
</abstract>
<kwd-group>
<kwd>nutrition supplements</kwd>
<kwd>dietary supplements</kwd>
<kwd>multivitamins</kwd>
<kwd>vitamins</kwd>
<kwd>ω-3 fatty acids</kwd>
<kwd><italic>Ginkgo biloba</italic></kwd>
<kwd>selenium</kwd>
<kwd>micronutrients</kwd>
<kwd>minerals</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0148607111416485">
<title>Clinical Relevancy Statement</title>
<p>The potential benefits and/or harm of nutrition supplements have significant clinical implications as more than half of the U.S. population takes nutrition supplements daily, and multivitamin-multimineral products are frequently prescribed by healthcare practitioners. The results of our study raise an alarm that this behavior may be harmful and that, with few exceptions, few data support the use of nutrition supplements.</p>
</sec>
<sec id="section2-0148607111416485" sec-type="intro">
<title>Introduction</title>
<p>A dietary supplement is defined as a product that is intended for use by humans to maintain and promote health and that contains 1 or more of the following ingredients: a vitamin, a mineral, a herb or other botanical, or an amino acid that is ingested in tablet, capsule, or liquid form.<sup><xref ref-type="bibr" rid="bibr1-0148607111416485">1</xref></sup> In the United States, dietary supplements are regulated under the Dietary Supplement Health and Education Act (DSHEA) of 1994.<sup><xref ref-type="bibr" rid="bibr1-0148607111416485">1</xref></sup> This act assumes that supplements, unlike drugs and food additives, are safe and effective. The DSHEA limits the control that the Food and Drug Administration (FDA) can exert over the dietary supplement industry.</p>
<p>Epidemiological data and cohort studies have suggested that dietary and supplemental B vitamins, ascorbic acid, folic acid, carotenoids, and tocopherols are associated with a decreased risk of cardiovascular disease and cancer.<sup><xref ref-type="bibr" rid="bibr2-0148607111416485">2</xref>-<xref ref-type="bibr" rid="bibr8-0148607111416485">8</xref></sup> Furthermore, numerous experimental studies have suggested favorable effects of several vitamins, minerals, and herbal products on oxidant damage, inflammation, immunity, DNA damage, and cell differentiation, proliferation, and apoptosis.<sup><xref ref-type="bibr" rid="bibr9-0148607111416485">9</xref>-<xref ref-type="bibr" rid="bibr11-0148607111416485">11</xref></sup> On the basis of this evidence, together with television and magazine advertisements, information obtained on the Internet, articles in the lay press, and the recommendations of their physicians, a large proportion of the U.S. population takes a variety of vitamin, mineral, and herbal supplements daily in the hopes of promoting good health, preventing chronic diseases (such as heart disease and cancer), limiting the ravages of aging, and ultimately extending life. The National Health and Nutrition Examination Survey (NHANES) 1999-2000 and other studies have demonstrated that <italic>over half</italic> the U.S. population regularly uses a dietary supplement, with &gt;35% reporting the regular use of a multivitamin-multimineral (MVMM) product.<sup><xref ref-type="bibr" rid="bibr12-0148607111416485">12</xref>-<xref ref-type="bibr" rid="bibr14-0148607111416485">14</xref></sup> Furthermore, at least half of supplement users report taking more than 1 supplement daily. According to the <italic>Nutrition Business Journal</italic>, annual sales of dietary supplements in the United States for 2008 were $25 billion.<sup><xref ref-type="bibr" rid="bibr15-0148607111416485">15</xref></sup> It has been estimated that 17% of this expenditure was spent on individual vitamins, 28% on MVMM, 14% on minerals, 11% on herbal supplements, and 31% on nonherbal supplements.<sup><xref ref-type="bibr" rid="bibr16-0148607111416485">16</xref></sup></p>
<p>More than 30,000 different dietary supplements are currently available in the United States.<sup><xref ref-type="bibr" rid="bibr17-0148607111416485">17</xref></sup> The most commonly used over-the-counter MVMM supplements contain at least 10 vitamins and 10 minerals usually at doses close to 100% of the recommend daily allowance (RDA = 2 standard deviations above the estimated average requirements). When combined with dietary intake, the total intake of selenium, zinc, phosphorus, magnesium, niacin, folic acid, and vitamins A, C, and E of supplement users in the United States exceeds 100% of the estimated average requirements (EAR), with the intake of vitamins C and E exceeding 700% of the EAR.<sup><xref ref-type="bibr" rid="bibr12-0148607111416485">12</xref>,<xref ref-type="bibr" rid="bibr14-0148607111416485">14</xref>,<xref ref-type="bibr" rid="bibr16-0148607111416485">16</xref>,<xref ref-type="bibr" rid="bibr18-0148607111416485">18</xref></sup> The most common herbal medicines used in Western countries include ginkgo (<italic>Ginkgo biloba</italic>), St John’s wort (Hypericum perforatum), stinging nettle (Urtica dioica), saw palmetto, mistletoe, and garlic. Many of the supplements presently available in the United States have uncertain quality control in their manufacture, and the user has no assurance about what he or she is taking. In addition, an increasing number of supplements contain products grown or manufactured overseas, where product purity and quality may vary significantly compared with agents manufactured in the United States.<sup><xref ref-type="bibr" rid="bibr19-0148607111416485">19</xref>,<xref ref-type="bibr" rid="bibr20-0148607111416485">20</xref></sup></p>
<p>Micronutrient deficiency, particularly vitamin A, and iron deficiency are a public health concern in more than half of all countries in the world, with most of the affected countries being in Africa or southeastern Asia.<sup><xref ref-type="bibr" rid="bibr21-0148607111416485">21</xref>,<xref ref-type="bibr" rid="bibr22-0148607111416485">22</xref></sup> According to recent statistics from the World Health Organization (WHO), an estimated 250 million preschool children in the world have vitamin A deficiency, and 250,000–500,000 of such children go blind every year.<sup><xref ref-type="bibr" rid="bibr21-0148607111416485">21</xref></sup> Randomized controlled trials conducted in children in developing nations have demonstrated that vitamin A supplementation decreases morbidity and all-cause mortality.<sup><xref ref-type="bibr" rid="bibr23-0148607111416485">23</xref>-<xref ref-type="bibr" rid="bibr26-0148607111416485">26</xref></sup> It is therefore likely that dietary supplements (particularly those containing vitamin A and iron) in children and pregnant women will have beneficial health outcomes in developing nations.<sup><xref ref-type="bibr" rid="bibr27-0148607111416485">27</xref></sup> However, the benefit of dietary supplements in nonpregnant adults in the United States and other Western nations is less clear. Given the fact that almost half of the U.S. population consumes dietary supplements on a regular basis, it is important to determine if indeed these substances meet the requirements as set out by the DSHEA, that is, they are safe and effective. An “influential review” of the benefits of vitamin supplements published in 2001 concluded that “a daily multivitamin that does not exceed the RDA of its components makes sense for most adults”; that “substantial evidence suggest that higher intake of folic acid, vitamin B6, vitamin B12 and vitamin D will benefit many people”; and that “vitamin E supplements are reasonable for most middle aged and older Americans who are at increased risk for coronary disease.”<sup><xref ref-type="bibr" rid="bibr28-0148607111416485">28</xref></sup> Since the publication of this review, a considerable number of randomized controlled trials testing the safety and efficacy of dietary supplements have been published.</p>
<p>The “gold-standard” approach to resolving whether a health practice offers benefit or harm to the public is through the conduct of well-designed and adequately powered randomized controlled trials. Randomized controlled trials are the only trial design for which causal inference can be established. Our goal was to systematically review the literature to identify those randomized controlled trials that investigated clinically relevant outcomes from the use of dietary supplements and then to synthesize and summarize these data.</p>
</sec>
<sec id="section3-0148607111416485">
<title>Search Strategy and Results</title>
<sec id="section4-0148607111416485">
<title>Identification of Trials</title>
<p>Our aim was to identify all relevant randomized controlled trials (RCTs) that evaluated the benefits and safety of dietary supplements. We restricted this analysis to human, nonpregnant adults and only included studies that evaluated clinical end points (including risk of acute myocardial infarction, stroke, cardiovascular death, risk of cancer, cancer recurrence, cancer death, risk of type 2 diabetes, risk of fractures, cognitive function, and all-cause mortality). We excluded studies performed in undernourished populations, patient groups with specific nutrition diseases, and pediatric and pregnant patients. We excluded studies that enrolled &lt;200 participants as such studies are likely to have unbalanced randomization of confounders and do not have statistical power to reliably detect a treatment effect (type II error).<sup><xref ref-type="bibr" rid="bibr29-0148607111416485">29</xref></sup> Furthermore, as it is likely that there would be a time delay between the consumption of a dietary supplement and discernable clinical outcomes, we excluded studies that were less than 1 year in duration. We recorded all outcomes for those studies reported in multiple publications. We used a multimethod approach to identify relevant studies for this review. Both authors independently searched the National Library of Medicine’s MEDLINE database for relevant studies in any language published from 1966 to December 2010 using the following Medical Subject Headings (MeSH) and keywords: dietary supplement or vitamins or Vitamin A or Vitamin B6 or Vitamin B12 or Vitamin D or Vitamin E or ascorbic acid or thiamine or folic acid or selenium(selenium compounds) or glucosamine or fatty acids, omega-3 or <italic>Ginkgo biloba</italic> or St John’s Wort (<italic>Hypericum perforatum</italic>) or Stinging Nettle (<italic>Urtica dioica</italic>) or Saw Palmetto or Milk Thistle or Garlic or Echinacea AND (limit) adult AND (limit) randomized controlled trial (publication type). In addition, we searched Embase and the Cochrane Database of Systematic Reviews. Bibliographies of all selected articles and review articles that included information on dietary supplements were reviewed for other relevant articles. In addition, we searched the “gray literature” to avoid any reporting bias; this included studies published in abstracts only. This search strategy was employed iteratively, until no new potential citations were found on review of the reference lists of retrieved articles. Our review was performed according to the guidelines proposed by the QUOROM group.<sup><xref ref-type="bibr" rid="bibr30-0148607111416485">30</xref></sup></p>
</sec>
<sec id="section5-0148607111416485">
<title>Data Extraction and Analysis</title>
<p>Both authors independently abstracted data from all studies using a standardized form. Data were abstracted on study design, study size, study setting, patient population, the country where the study was performed, the year of publication, the dietary supplement(s) investigated and dosages, the duration of the study/observation period, and all outcomes. We provided the outcomes of each study individually and in a semiquantitative manner classified the outcomes of each study as nonbeneficial, beneficial, or harmful according to whether the end point(s) of interest in each study reached statistical significance. We were then able to determine the number of studies that showed no benefit, benefit, or harm overall for each dietary supplement.</p>
</sec>
</sec>
<sec id="section6-0148607111416485" sec-type="results">
<title>Results</title>
<p>The initial search strategy generated 6224 citations; of these, 3322 were excluded as the study was not relevant to our review. The abstracts of the remaining 2902 studies were reviewed. A further 1510 were excluded because of study design (no placebo arm, inadequate randomization), duplicate publication, or a failure to report an outcome variable of interest. An additional 1340 studies were excluded because of inadequate sample size, inadequate duration of follow-up, or nontarget population. An additional 11 studies were identified from the bibliographies of the selected articles and review articles. No studies were identified that were published in abstracts only.</p>
<p>Sixty-three studies met the criteria for our systematic review. These studies enrolled a total of 428,357 patients with an average of 6693 patients per study and a mean duration of 4.7 years. These studies are summarized in <xref ref-type="table" rid="table1-0148607111416485">Table 1</xref>. The included studies evaluated β-carotene; vitamins A, B6, B12, C, D, and E; folic acid; calcium; selenium; ω-3 fatty acids; <italic>G biloba;</italic> glucosamine; saw palmetto; and milk thistle. No randomized controlled studies investigating St John’s wort, stinging nettle, echinacea, or garlic met our inclusion criteria. No benefit was recorded in 45 studies, with 10 of these showing a trend toward harm and 2 showing a trend toward benefit. Four studies reported harm, with an increased risk of cancer and cancer deaths in the Carotene and Retinol Efficacy Trial (CARET) and the Norwegian Vitamin Trial II (NORVIT II) studies and an increased risk of fractures in the 2 studies that investigated high-dose once-yearly vitamin D. The Nutritional Cancer Prevention Study (selenium supplementation) demonstrated both benefit (less cancer) and harm (increased risk of type 2 diabetes). The lower risk of cancer with selenium supplementation, however, was not confirmed in the much larger Selenium and Vitamin E Cancer Prevention Trial (SELECT). Similarly, the Calcium Polyp Prevention Study demonstrated both a benefit (reduced fractures and reduced polyps) and harm (increased acute myocardial infarction). A beneficial outcome was reported in 12 studies; 6 studied vitamin D and 3 investigated ω-3 fatty acids. The benefits of vitamin D appeared to be dose dependent. Although a benefit was reported in 1 study each that investigated vitamin E, folic acid, and <italic>G biloba</italic>, this benefit was not confirmed by larger and more adequately powered studies.</p>
<table-wrap id="table1-0148607111416485" position="float">
<label>Table 1.</label>
<caption>
<p>Randomized Controlled Trials of Dietary Supplements</p>
</caption>
<graphic alternate-form-of="table1-0148607111416485" xlink:href="10.1177_0148607111416485-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Supplement</th>
<th align="center">Study Name/Author</th>
<th align="center">Country</th>
<th align="center">n</th>
<th align="center">Duration, y</th>
<th align="center">Population</th>
<th align="center">End Point</th>
<th align="center">Outcome</th>
</tr>
</thead>
<tbody>
<tr>
<td>β-carotene</td>
<td>Skin Cancer Prevention Study<sup><xref ref-type="bibr" rid="bibr49-0148607111416485">49</xref></sup></td>
<td>United States</td>
<td>1805</td>
<td>5</td>
<td>Recent skin cancer</td>
<td>Recurrent skin cancer</td>
<td>No benefit</td>
</tr>
<tr>
<td>β-carotene</td>
<td>Nambour Skin Prevention Trial<sup><xref ref-type="bibr" rid="bibr50-0148607111416485">50</xref></sup></td>
<td>Australia</td>
<td>1621</td>
<td>4.5</td>
<td>Skin cancer</td>
<td>Skin cancer</td>
<td>No benefit</td>
</tr>
<tr>
<td>β-carotene</td>
<td>The Physicians Health Study<sup><xref ref-type="bibr" rid="bibr51-0148607111416485">51</xref></sup></td>
<td>United States</td>
<td>22,071</td>
<td>12</td>
<td>M physicians</td>
<td>CVS, cancer</td>
<td>No benefit</td>
</tr>
<tr>
<td>β-carotene</td>
<td>Women’s Health Study<sup><xref ref-type="bibr" rid="bibr52-0148607111416485">52</xref></sup></td>
<td>United States</td>
<td>39,876</td>
<td>4.1</td>
<td>F professionals</td>
<td>CVS, cancer</td>
<td>No benefit</td>
</tr>
<tr>
<td>Vitamin A, β-carotene</td>
<td>CARET<sup><xref ref-type="bibr" rid="bibr53-0148607111416485">53</xref></sup></td>
<td>United States</td>
<td>18,314</td>
<td>4.0</td>
<td>Smokers and asbestos</td>
<td>CVS, lung cancer</td>
<td>HARM, including lung cancer</td>
</tr>
<tr>
<td>Vitamin E</td>
<td>Cambridge Heart Antioxidant Study<sup><xref ref-type="bibr" rid="bibr54-0148607111416485">54</xref></sup></td>
<td>United Kingdom</td>
<td>2002</td>
<td>1.4</td>
<td>CAD</td>
<td>CVS</td>
<td>BENEFIT</td>
</tr>
<tr>
<td>Vitamin E</td>
<td>Women’s Health Study<sup><xref ref-type="bibr" rid="bibr55-0148607111416485">55</xref>,<xref ref-type="bibr" rid="bibr56-0148607111416485">56</xref></sup></td>
<td>United States</td>
<td>39,876</td>
<td>10.1</td>
<td>Female professionals</td>
<td>CVS, cancer</td>
<td>No benefit</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>6377</td>
<td>9.6</td>
<td>Female professionals</td>
<td>Cognitive function</td>
<td>No benefit</td>
</tr>
<tr>
<td>Vitamin E</td>
<td>HOPE<sup><xref ref-type="bibr" rid="bibr57-0148607111416485">57</xref></sup></td>
<td>Canada</td>
<td>2545</td>
<td>4.5</td>
<td>Risk for CAD</td>
<td>CVS</td>
<td>No benefit</td>
</tr>
<tr>
<td>Vitamin E</td>
<td>Primary Prevention Project<sup><xref ref-type="bibr" rid="bibr58-0148607111416485">58</xref></sup></td>
<td>Italy</td>
<td>4495</td>
<td>3.6</td>
<td>Risk for CAD</td>
<td>CVS</td>
<td>No benefit</td>
</tr>
<tr>
<td>Vitamin E</td>
<td>DATATOP<sup><xref ref-type="bibr" rid="bibr59-0148607111416485">59</xref>,<xref ref-type="bibr" rid="bibr60-0148607111416485">60</xref></sup></td>
<td>United States</td>
<td>800</td>
<td>1.2</td>
<td>Early Parkinson disease</td>
<td>Disease progression</td>
<td>No benefit</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>800</td>
<td>3</td>
<td>Early Parkinson disease</td>
<td>Mortality</td>
<td>No benefit, questionable harm, including death</td>
</tr>
<tr>
<td>Vitamin E</td>
<td>Vitamin E Prevention Study<sup><xref ref-type="bibr" rid="bibr61-0148607111416485">61</xref></sup></td>
<td>United States</td>
<td>353</td>
<td>3</td>
<td>&gt;40 y + including LDL</td>
<td>CVS, cancer</td>
<td>No benefit</td>
</tr>
<tr>
<td>Vitamin E, β-carotene</td>
<td>ATBC cancer prevention study<sup><xref ref-type="bibr" rid="bibr62-0148607111416485">62</xref></sup></td>
<td>Finland</td>
<td>29,133</td>
<td>8</td>
<td>Smokers</td>
<td>Lung cancer</td>
<td>No benefit, questionable harm, including cancer</td>
</tr>
<tr>
<td>Vitamins E, C</td>
<td>Physicians Health Study II<sup><xref ref-type="bibr" rid="bibr63-0148607111416485">63</xref>,<xref ref-type="bibr" rid="bibr64-0148607111416485">64</xref></sup></td>
<td>United States</td>
<td>14,641</td>
<td>8</td>
<td>M physicians &gt;50 y</td>
<td>CVS, cancer</td>
<td>No benefit, questionable harm, including stroke</td>
</tr>
<tr>
<td>Vitamins E, C</td>
<td>WAVE Trial<sup><xref ref-type="bibr" rid="bibr65-0148607111416485">65</xref></sup></td>
<td>United States + Canada</td>
<td>423</td>
<td>2.8</td>
<td>Females with CAD</td>
<td>CVS</td>
<td>No benefit, questionable harm, including CVS, death</td>
</tr>
<tr>
<td>Vitamins E, C; β-carotene</td>
<td>Polyp prevention study<sup><xref ref-type="bibr" rid="bibr66-0148607111416485">66</xref></sup></td>
<td>United States</td>
<td>864</td>
<td>4</td>
<td>Colorectal adenoma</td>
<td>Recurrence</td>
<td>No benefit</td>
</tr>
<tr>
<td>Vitamins E, C; β-carotene</td>
<td>Women’s antioxidant study<sup><xref ref-type="bibr" rid="bibr67-0148607111416485">67</xref>,<xref ref-type="bibr" rid="bibr68-0148607111416485">68</xref></sup></td>
<td>United States</td>
<td>8171</td>
<td>9.2</td>
<td>Females with CAD risk</td>
<td>CVS, diabetes</td>
<td>No benefit</td>
</tr>
<tr>
<td>Vitamins E, C; β-carotene</td>
<td>MRC Heart protection study<sup><xref ref-type="bibr" rid="bibr69-0148607111416485">69</xref></sup></td>
<td>United Kingdom</td>
<td>20,536</td>
<td>5</td>
<td>CAD or diabetes</td>
<td>CVS</td>
<td>No benefit</td>
</tr>
<tr>
<td>Vitamin E, selenium</td>
<td>SELECT trial<sup><xref ref-type="bibr" rid="bibr70-0148607111416485">70</xref></sup></td>
<td>United States + Canada</td>
<td>35,533</td>
<td>5.4</td>
<td>M &gt;50 y</td>
<td>Cancer</td>
<td>No benefit, questionable harm, including cancer, type 2 diabetes</td>
</tr>
<tr>
<td>Vitamins E, C; β-carotene<sup><xref ref-type="table-fn" rid="table-fn2-0148607111416485">a</xref></sup></td>
<td>SU.VI.MAX Study<sup><xref ref-type="bibr" rid="bibr71-0148607111416485">71</xref></sup></td>
<td>France</td>
<td>13,017</td>
<td>7.5</td>
<td>Middle aged &lt;60 y</td>
<td>CVS, cancer, death</td>
<td>No benefit</td>
</tr>
<tr>
<td>Vitamin E vs MMV</td>
<td>Graat et al<sup><xref ref-type="bibr" rid="bibr72-0148607111416485">72</xref></sup></td>
<td>Netherlands</td>
<td>652</td>
<td>1.2</td>
<td>&gt;60 y</td>
<td>Respiratory infections</td>
<td>No benefit, questionable harm; severe infection</td>
</tr>
<tr>
<td>Vitamin E</td>
<td>Vitamin E cataract study<sup><xref ref-type="bibr" rid="bibr73-0148607111416485">73</xref></sup></td>
<td>Australia</td>
<td>1193</td>
<td>4</td>
<td>55-80 y</td>
<td>Cataracts</td>
<td>No benefit</td>
</tr>
<tr>
<td>Vitamins E, C; β-carotene</td>
<td>REACT<sup><xref ref-type="bibr" rid="bibr74-0148607111416485">74</xref></sup></td>
<td>United States + United Kingdom</td>
<td>297</td>
<td>3</td>
<td>Early cataract</td>
<td>Cataract progression</td>
<td>Questionable benefit</td>
</tr>
<tr>
<td>Vitamins E, C; β-carotene, zinc</td>
<td>AREDS<sup><xref ref-type="bibr" rid="bibr75-0148607111416485">75</xref>,<xref ref-type="bibr" rid="bibr76-0148607111416485">76</xref></sup></td>
<td>United States</td>
<td>3640</td>
<td>6.3</td>
<td>Macular degeneration</td>
<td>Visual acuity</td>
<td>Questionable benefit</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>4757</td>
<td>6.3</td>
<td>Macular degeneration</td>
<td>Lens opacification</td>
<td>No benefit</td>
</tr>
<tr>
<td>Folic acid</td>
<td>Health Professional Study<sup><xref ref-type="bibr" rid="bibr77-0148607111416485">77</xref></sup></td>
<td>United States</td>
<td>672</td>
<td>5.3</td>
<td>Colorectal adenoma</td>
<td>Recurrence</td>
<td>No benefit</td>
</tr>
<tr>
<td>Folic acid</td>
<td>ukCAP trial<sup><xref ref-type="bibr" rid="bibr78-0148607111416485">78</xref></sup></td>
<td>England</td>
<td>467</td>
<td>3.0</td>
<td>Colorectal adenoma</td>
<td>Recurrence</td>
<td>No benefit</td>
</tr>
<tr>
<td>Folic acid</td>
<td>Poly Prevention Study<sup><xref ref-type="bibr" rid="bibr79-0148607111416485">79</xref></sup></td>
<td>United States</td>
<td>1021</td>
<td>3.4</td>
<td>Colorectal adenoma</td>
<td>Recurrence, cancer</td>
<td>No benefit, questionable harm, including cancer</td>
</tr>
<tr>
<td>Folic acid</td>
<td>FACIT<sup><xref ref-type="bibr" rid="bibr80-0148607111416485">80</xref></sup></td>
<td>Netherlands<sup><xref ref-type="table-fn" rid="table-fn3-0148607111416485">b</xref></sup></td>
<td>818</td>
<td>3</td>
<td>&gt;50 y + homocysteine<sup><xref ref-type="table-fn" rid="table-fn4-0148607111416485">c</xref></sup></td>
<td>Cognitive function</td>
<td>BENEFIT</td>
</tr>
<tr>
<td>Folic acid, vitamin B12</td>
<td>SEARCH<sup><xref ref-type="bibr" rid="bibr81-0148607111416485">81</xref></sup></td>
<td>United Kingdom</td>
<td>12,064</td>
<td>6.7</td>
<td>Previous AMI</td>
<td>CVS</td>
<td>No benefit</td>
</tr>
<tr>
<td>Folic acid; vitamins B6, B12</td>
<td>WAFACS<sup><xref ref-type="bibr" rid="bibr82-0148607111416485">82</xref>-<xref ref-type="bibr" rid="bibr84-0148607111416485">84</xref></sup></td>
<td>United States</td>
<td>5442</td>
<td>7.3</td>
<td>F + CVS risk</td>
<td>CVS, cancer, death</td>
<td>No benefit</td>
</tr>
<tr>
<td>Folic acid; vitamins B6, B12</td>
<td>Aisen et al<sup><xref ref-type="bibr" rid="bibr85-0148607111416485">85</xref></sup></td>
<td>United States</td>
<td>409</td>
<td>1.5</td>
<td>Mild Alzheimer disease</td>
<td>Change in cognition</td>
<td>No benefit, questionable harm, including depression</td>
</tr>
<tr>
<td>Folic acid; vitamins B6, B12</td>
<td>WENBIT<sup><xref ref-type="bibr" rid="bibr86-0148607111416485">86</xref></sup></td>
<td>Norway</td>
<td>3096</td>
<td>3.2</td>
<td>CAD</td>
<td>CVS</td>
<td>No benefit</td>
</tr>
<tr>
<td>Folic acid; vitamins B6, B12</td>
<td>NORVIT I<sup><xref ref-type="bibr" rid="bibr87-0148607111416485">87</xref></sup></td>
<td>Norway</td>
<td>3749</td>
<td>3.3</td>
<td>CAD</td>
<td>CVS</td>
<td>No benefit questionable, harm, including CVS</td>
</tr>
<tr>
<td>Folic acid; vitamins B6, B12</td>
<td>NORVIT II<sup><xref ref-type="bibr" rid="bibr88-0148607111416485">88</xref></sup></td>
<td>Norway</td>
<td>6837</td>
<td>6.4</td>
<td>CAD</td>
<td>Cancer, mortality</td>
<td>HARM, including cancer, death</td>
</tr>
<tr>
<td>Folic acid; vitamins B6, B12</td>
<td>HOPE II<sup><xref ref-type="bibr" rid="bibr89-0148607111416485">89</xref></sup></td>
<td>Canada</td>
<td>5522</td>
<td>5.0</td>
<td>Vascular disease/diabetes</td>
<td>CVS</td>
<td>No benefit</td>
</tr>
<tr>
<td>Folic acid; vitamins B6, B12</td>
<td>McMahon et al<sup><xref ref-type="bibr" rid="bibr90-0148607111416485">90</xref></sup></td>
<td>New Zealand</td>
<td>276</td>
<td>2.0</td>
<td>&gt;65 y + homocysteine<sup><xref ref-type="table-fn" rid="table-fn4-0148607111416485">c</xref></sup></td>
<td>Change in cognition</td>
<td>No benefit</td>
</tr>
<tr>
<td>Folic acid; vitamins B6, B12</td>
<td>VISP<sup><xref ref-type="bibr" rid="bibr91-0148607111416485">91</xref></sup></td>
<td>United States</td>
<td>3680</td>
<td>2.0</td>
<td>Cerebral infarct</td>
<td>Stroke, CVS, death</td>
<td>No benefit</td>
</tr>
<tr>
<td>Vitamin D (400 IU), calcium</td>
<td>Women’s Health Initiative<sup><xref ref-type="bibr" rid="bibr92-0148607111416485">92</xref>-<xref ref-type="bibr" rid="bibr95-0148607111416485">95</xref></sup></td>
<td>United States</td>
<td>36,282</td>
<td>7.0</td>
<td>Postmenopausal women</td>
<td>Fractures, cancer, CVS, death</td>
<td>No benefit</td>
</tr>
<tr>
<td>Vitamin D (800 IU), calcium</td>
<td>Porthouse et al<sup><xref ref-type="bibr" rid="bibr96-0148607111416485">96</xref></sup></td>
<td>United Kingdom</td>
<td>3314</td>
<td>2.0</td>
<td>F &gt;70 y + fracture risk</td>
<td>Fracture</td>
<td>No benefit</td>
</tr>
<tr>
<td>Vitamin D (800 IU), calcium</td>
<td>RECORD<sup><xref ref-type="bibr" rid="bibr97-0148607111416485">97</xref></sup></td>
<td>United Kingdom</td>
<td>5292</td>
<td>2.0</td>
<td>&gt;70 y + fracture</td>
<td>New fracture</td>
<td>No benefit</td>
</tr>
<tr>
<td>Vitamin D (700 IU), calcium</td>
<td>Dawson-Hughes et al<sup><xref ref-type="bibr" rid="bibr98-0148607111416485">98</xref></sup></td>
<td>United States</td>
<td>389</td>
<td>3.0</td>
<td>&gt;65 y</td>
<td>Fractures</td>
<td>BENEFIT</td>
</tr>
<tr>
<td>Vitamin D (800 IU), calcium</td>
<td>Chapuy et al<sup><xref ref-type="bibr" rid="bibr99-0148607111416485">99</xref></sup></td>
<td>France</td>
<td>3270</td>
<td>3.0</td>
<td>F mobile elderly</td>
<td>Fractures</td>
<td>BENEFIT</td>
</tr>
<tr>
<td>Vitamin D (100 IU), calcium</td>
<td>Prince et al<sup><xref ref-type="bibr" rid="bibr100-0148607111416485">100</xref></sup></td>
<td>Australia</td>
<td>302</td>
<td>1.0</td>
<td>70-90 y</td>
<td>Falls</td>
<td>BENEFIT</td>
</tr>
<tr>
<td>Vitamin D (1100 IU), calcium</td>
<td>Lappe et al<sup><xref ref-type="bibr" rid="bibr101-0148607111416485">101</xref></sup></td>
<td>United States</td>
<td>1179</td>
<td>4.0</td>
<td>Postmenopausal women</td>
<td>Cancer</td>
<td>BENEFIT</td>
</tr>
<tr>
<td>Vitamin D (400 IU)</td>
<td>Meyer et al<sup><xref ref-type="bibr" rid="bibr102-0148607111416485">102</xref></sup></td>
<td>Norway</td>
<td>1144</td>
<td>2.0</td>
<td>Mobile NH residents</td>
<td>Fractures and death</td>
<td>No benefit</td>
</tr>
<tr>
<td>Vitamin D (400 IU)</td>
<td>Lips et al<sup><xref ref-type="bibr" rid="bibr103-0148607111416485">103</xref></sup></td>
<td>Holland</td>
<td>2578</td>
<td>3.5</td>
<td>&gt;70 y</td>
<td>Fractures and death</td>
<td>No benefit</td>
</tr>
<tr>
<td>Vitamin D (100,000 IU)<sup><xref ref-type="table-fn" rid="table-fn5-0148607111416485">d</xref></sup></td>
<td>Trevidi et al<sup><xref ref-type="bibr" rid="bibr104-0148607111416485">104</xref></sup></td>
<td>England</td>
<td>2686</td>
<td>5.0</td>
<td>65-85 y</td>
<td>Fractures and death</td>
<td>BENEFIT</td>
</tr>
<tr>
<td>Vitamin D (calcitriol<sup><xref ref-type="table-fn" rid="table-fn6-0148607111416485">e</xref></sup>)</td>
<td>Gallagher et al<sup><xref ref-type="bibr" rid="bibr105-0148607111416485">105</xref></sup></td>
<td>United States</td>
<td>498</td>
<td>3.0</td>
<td>65-77 y</td>
<td>Falls</td>
<td>BENEFIT</td>
</tr>
<tr>
<td>Vitamin D (300,000 IU/y)</td>
<td>Smith et al<sup><xref ref-type="bibr" rid="bibr106-0148607111416485">106</xref></sup></td>
<td>England</td>
<td>9440</td>
<td>3.0</td>
<td>&gt;75 y</td>
<td>Fractures and falls</td>
<td>HARM, including fractures</td>
</tr>
<tr>
<td>Vitamin D (500,000 IU/y)</td>
<td>Sanders et al<sup><xref ref-type="bibr" rid="bibr107-0148607111416485">107</xref></sup></td>
<td>Australia</td>
<td>2256</td>
<td>4.0</td>
<td>F &gt;70 y</td>
<td>Fractures and falls</td>
<td>HARM, including fractures and falls</td>
</tr>
<tr>
<td>Calcium</td>
<td>Prince et al<sup><xref ref-type="bibr" rid="bibr108-0148607111416485">108</xref></sup></td>
<td>United States</td>
<td>1460</td>
<td>5.0</td>
<td>F &gt;70 y</td>
<td>Fractures</td>
<td>No benefit</td>
</tr>
<tr>
<td>Calcium</td>
<td>Bolland et al<sup><xref ref-type="bibr" rid="bibr109-0148607111416485">109</xref></sup></td>
<td>New Zealand</td>
<td>1471</td>
<td>5.0</td>
<td>Postmenopausal women</td>
<td>CVS</td>
<td>No benefit questionable, harm, including AMI</td>
</tr>
<tr>
<td>Calcium</td>
<td>Calcium Polyp Prevention Study<sup><xref ref-type="bibr" rid="bibr110-0148607111416485">110</xref>,<xref ref-type="bibr" rid="bibr111-0148607111416485">111</xref></sup></td>
<td>United States</td>
<td>930</td>
<td>10.5</td>
<td>&lt;80 y, recent adenoma</td>
<td>Fractures</td>
<td>BENEFIT</td>
</tr>
<tr>
<td/>
<td/>
<td/><td>930</td>
<td>4.0</td>
<td>&lt;80 y, recent adenoma</td>
<td>Recurrent polyp, CVS</td>
<td>Reduced polyp; questionable harm, including AMI</td>
</tr>
<tr>
<td>Selenium</td>
<td>Nutritional Cancer Prevention Study<sup><xref ref-type="bibr" rid="bibr112-0148607111416485">112</xref>-<xref ref-type="bibr" rid="bibr114-0148607111416485">114</xref></sup></td>
<td>United States</td>
<td>1312</td>
<td>4.5</td>
<td>Patients with previous skin cancer</td>
<td>Cancer, death</td>
<td>BENEFIT</td>
</tr>
<tr>
<td/>
<td/>
<td/><td>1202</td>
<td>7.7</td>
<td>Patients with previous skin cancer</td>
<td>Type II diabetes</td>
<td>HARM</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>1004</td>
<td>7.6</td>
<td>Patients with previous skin cancer</td>
<td>CVS</td>
<td>No benefit</td>
</tr>
<tr>
<td>ω-3 vs vitamin E</td>
<td>GISSI Prevenzione Trial<sup><xref ref-type="bibr" rid="bibr115-0148607111416485">115</xref></sup></td>
<td>Italy</td>
<td>11,324</td>
<td>3.5</td>
<td>Recent AMI</td>
<td>CVS</td>
<td>BENEFIT</td>
</tr>
<tr>
<td>ω-3</td>
<td>JELIS<sup><xref ref-type="bibr" rid="bibr116-0148607111416485">116</xref></sup></td>
<td>Japan</td>
<td>18,645</td>
<td>4.6</td>
<td>Total cholesterol &gt;250 mg/dL</td>
<td>CVS</td>
<td>BENEFIT</td>
</tr>
<tr>
<td>ω-3</td>
<td>GISSI Heart Failure Trial<sup><xref ref-type="bibr" rid="bibr117-0148607111416485">117</xref></sup></td>
<td>Italy</td>
<td>6975</td>
<td>3.9</td>
<td>Heart failure</td>
<td>CVS</td>
<td>BENEFIT</td>
</tr>
<tr>
<td>ωa-3</td>
<td>OPAL<sup><xref ref-type="bibr" rid="bibr118-0148607111416485">118</xref></sup></td>
<td>England</td>
<td>867</td>
<td>2.0</td>
<td>70-79 y</td>
<td>Cognitive function</td>
<td>No benefit</td>
</tr>
<tr>
<td>ω-3</td>
<td>Quinn et al<sup><xref ref-type="bibr" rid="bibr119-0148607111416485">119</xref></sup></td>
<td>United States</td>
<td>402</td>
<td>1.5</td>
<td>Mild dementia</td>
<td>Cognitive function</td>
<td>No benefit</td>
</tr>
<tr>
<td><italic>Ginkgo biloba</italic></td>
<td>North American EGb Study Group<sup><xref ref-type="bibr" rid="bibr120-0148607111416485">120</xref></sup></td>
<td>United States</td>
<td>309</td>
<td>2.0</td>
<td>Alzheimer dementia</td>
<td>Cognitive function</td>
<td>BENEFIT</td>
</tr>
<tr>
<td><italic>Ginkgo biloba</italic></td>
<td>GEM Study Group<sup><xref ref-type="bibr" rid="bibr121-0148607111416485">121</xref>,<xref ref-type="bibr" rid="bibr122-0148607111416485">122</xref></sup></td>
<td>United States</td>
<td>3069</td>
<td>6.1</td>
<td>&gt;75 y</td>
<td>Cognitive function, CVS</td>
<td>No benefit</td>
</tr>
<tr>
<td>Glucosamine</td>
<td>Wilkens et al<sup><xref ref-type="bibr" rid="bibr123-0148607111416485">123</xref></sup></td>
<td>Finland</td>
<td>250</td>
<td>1.0</td>
<td>Low back pain</td>
<td>Pain + disability</td>
<td>No benefit</td>
</tr>
<tr>
<td>Saw palmetto</td>
<td>Bent et al<sup><xref ref-type="bibr" rid="bibr124-0148607111416485">124</xref></sup></td>
<td>United States</td>
<td>225</td>
<td>1.0</td>
<td>Prostatic hypertrophy</td>
<td>Symptom score</td>
<td>No benefit</td>
</tr>
<tr>
<td>Milk thistle</td>
<td>Pares et al<sup><xref ref-type="bibr" rid="bibr125-0148607111416485">125</xref></sup></td>
<td>Spain</td>
<td>200</td>
<td>2.0</td>
<td>Alcoholic cirrhosis</td>
<td>Disease progression, death</td>
<td>No benefit</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0148607111416485">
<p>AMI, acute myocardial infarction; AREDS, Age-Related Eye Disease Study; ATBC, Alpha-Tocopherol, Beta Carotene; CAD, coronary artery disease; CARET, Carotene and Retinol Efficacy Trial; CVS, cardiovascular event; DATATOP, Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism trial; FACIT, Folic Acid and Carotid Intima-Media Thickness trial; F, female; GEM, Ginkgo Evaluation of Memory; GISSI, Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico; HOPE, Heart Outcomes Prevention Evaluation; JELIS, Japan EPA Lipid Intervention Study; LDL, low-density lipoprotein; M, male; MMV, multivitamin and mineral; MRC, Medical Research Council; NH, nursing home; NORVIT, Norwegian Vitamin Trial; OPAL, Older People and n-3 Long-Chain Polyunsaturated Fatty Acids study; REACT, Roche European American Cataract Trial; RECORD, Randomised Evaluation of Calcium or Vitamin D trial; SEARCH, Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine; SELECT, Selenium and Vitamin E Cancer Prevention Trial; SU.VI.MAX, Supplémentation en Vitamines et Minéraux Antioxydants; VISP, Vitamin Intervention for Stroke Prevention; WAFACS, Women’s Antioxidant and Folic Acid Cardiovascular Study; WAVE, Women’s Angiographic Vitamin and Estrogen trial; WENBIT, Western Norway B Vitamin Intervention Trial.</p></fn>
<fn id="table-fn2-0148607111416485">
<label>a</label>
<p>Selenium and zinc added.</p>
</fn>
<fn id="table-fn3-0148607111416485">
<label>b</label>
<p>No mandatory folic acid fortification.</p>
</fn>
<fn id="table-fn4-0148607111416485">
<label>c</label>
<p>Plasma homocysteine &gt;13 µmol/L.</p>
</fn>
<fn id="table-fn5-0148607111416485">
<label>d</label>
<p>Every 4 months.</p>
</fn>
<fn id="table-fn6-0148607111416485">
<label>e</label>
<p>0.25 µg/d.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section7-0148607111416485" sec-type="discussion">
<title>Discussion</title>
<p>The results of our study demonstrate that with the possible exceptions of vitamin D (in elderly patients) and ω-3 fatty acids (in patients with cardiovascular disease), no data support the widespread use of dietary supplements in Westernized populations; indeed, the data suggest that certain commonly used dietary supplements (β-carotene, vitamin A, and vitamin E) may be harmful. Our findings are supported by a meta-analysis by Bjelakovic and colleagues,<sup><xref ref-type="bibr" rid="bibr31-0148607111416485">31</xref></sup> who demonstrated that β-carotene (relative risk [RR], 1.07; 95% confidence interval [CI], 1.02–1.11), vitamin A (1.16; 1.1–1.24), and vitamin E (1.04; 1.01–1.07) singly or in combination significantly increased mortality. According to the Institute of Medicine’s (IOM’s) categorization of vitamin D status based on serum 25-hydroxyvitamin D (25OHD),<sup><xref ref-type="bibr" rid="bibr32-0148607111416485">32</xref></sup> data from the most recent NHANES (2001-2006) indicate that only 8% of the U.S. population are “at risk of vitamin D deficiency” (serum 25OHD &lt;30 nmol/L). <sup><xref ref-type="bibr" rid="bibr33-0148607111416485">33</xref></sup> This finding may partly explain the limited benefit of vitamin D supplementation. In addition, vitamin D3 in doses of &lt;700 IU/d appears to have no beneficial effect on health outcomes. Data from a limited number of studies suggest that vitamin D3 in a dose in excess of 699 IU/d may reduce the risk of falls, osteoporotic fractures, and the risk of cancer in elderly patients.<sup><xref ref-type="bibr" rid="bibr34-0148607111416485">34</xref>-<xref ref-type="bibr" rid="bibr36-0148607111416485">36</xref></sup> However, high-dose vitamin D given once yearly appears paradoxically to increase the risk of fractures. Calcium supplementation alone may increase the risk of myocardial infarction.<sup><xref ref-type="bibr" rid="bibr37-0148607111416485">37</xref></sup> It is important to note that most multivitamins contain &lt;700 IU of vitamin D3. The IOM’s updated (2010) dietary reference intake for vitamin D lists the RDA as 600 IU/d for adults younger than 70 years and 800 IU/d for adults older than 70 years.<sup><xref ref-type="bibr" rid="bibr32-0148607111416485">32</xref></sup> However, the International Osteoporosis Foundation in its most recent guidelines (2010) suggests that the average vitamin D requirement for older adults is between 800 and 1000 IU/d.<sup><xref ref-type="bibr" rid="bibr38-0148607111416485">38</xref></sup> Because of the conflicting data and varying recommendations, additional studies are required before vitamin D supplementation can be widely recommended.<sup><xref ref-type="bibr" rid="bibr32-0148607111416485">32</xref>,<xref ref-type="bibr" rid="bibr35-0148607111416485">35</xref>,<xref ref-type="bibr" rid="bibr36-0148607111416485">36</xref>,<xref ref-type="bibr" rid="bibr38-0148607111416485">38</xref>-<xref ref-type="bibr" rid="bibr41-0148607111416485">41</xref></sup> Supplementation with ω-3 fatty acids (2–4 g/d) appears to be effective in reducing angina, acute myocardial infarction, and cardiovascular death in patients with cardiovascular disease.</p>
<p>Dietary supplements in Westernized populations are frequently used to compensate for a poor diet and an unhealthy lifestyle. Dietary supplements do not contain proteins, essential fatty acids, fiber, phytochemicals, and other important compounds (both known and unknown) found in fruits and vegetables. Although there are limited scientific data to recommend the use of dietary supplements, an emerging body of evidence suggests that lifestyle modification, which includes dietary interventions and exercise, improves health outcomes.<sup><xref ref-type="bibr" rid="bibr42-0148607111416485">42</xref>-<xref ref-type="bibr" rid="bibr47-0148607111416485">47</xref></sup></p>
<p>The practice of medicine as taught in U.S. medical schools is grounded in the scientific method and stresses the use of evidence in patient care decisions. Before a drug is administered to humans, its efficacy and safety must be established in well-designed trials, and the FDA must approve its use. We believe that dietary supplements should be held to the same level of evidence and regulatory standards.</p>
<p>Our article has a number of limitations. Most notably, the studies included in our systematic review were very heterogeneous, involving many different patient groups and many supplementation regimens, with differing study designs and widely differing end points. We were therefore unable to perform a traditional meta-analysis but rather presented the outcomes of each study in a semiquantitative manner (beneficial, neural, or harmful). We believe that this is a useful approach to answering the important question posed.<sup><xref ref-type="bibr" rid="bibr48-0148607111416485">48</xref></sup> Furthermore, our findings are limited by the methodological quality of the original studies, and for many supplements, limited or no “high-quality” data were available. However, we believe that the findings of our study are valid in that very little experimental data support the notion that vitamin and mineral supplements have beneficial pharmacological properties in those individuals not deficient in the particular vitamin or mineral that is supplemented.</p>
<p>In conclusion, the results of our study provide little evidence to support the current levels of dietary supplement use in the United States and other Western nations. Additional long-term RCTs are required to determine the health benefits of dietary supplements. However, as cost constraints preclude RCTs that extend decades, prospective cohort and case control studies are needed to discern the impact of supplements on chronic, long-term health outcomes.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p>Financial disclosure: None declared.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0148607111416485">
<label>1.</label>
<citation citation-type="journal">
<comment>Dietary Supplement Health and Education Act (DSHEA), Public Law 103-417</comment> (<year>1994</year>).</citation>
</ref>
<ref id="bibr2-0148607111416485">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Block</surname><given-names>G</given-names></name>
<name><surname>Patterson</surname><given-names>B</given-names></name>
<name><surname>Subar</surname><given-names>A</given-names></name>
</person-group>. <article-title>Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence</article-title>. <source>Nutr Cancer</source>. <year>1992</year>;<volume>18</volume>:<fpage>1</fpage>-<lpage>29</lpage>.</citation>
</ref>
<ref id="bibr3-0148607111416485">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Giovannucci</surname><given-names>E</given-names></name>
<name><surname>Stampfer</surname><given-names>MJ</given-names></name>
<name><surname>Colditz</surname><given-names>GA</given-names></name>
<etal/>
</person-group>. <article-title>Multivitamin use, folate, and colon cancer in women in the Nurses’ Health Study</article-title>. <source>Ann Intern Med</source>. <year>1998</year>;<volume>129</volume>:<fpage>517</fpage>-<lpage>524</lpage>.</citation>
</ref>
<ref id="bibr4-0148607111416485">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>S</given-names></name>
<name><surname>Hunter</surname><given-names>DJ</given-names></name>
<name><surname>Hankinson</surname><given-names>SE</given-names></name>
<etal/>
</person-group>. <article-title>A prospective study of folate intake and the risk of breast cancer</article-title>. <source>JAMA</source>. <year>1999</year>;<volume>281</volume>:<fpage>1632</fpage>-<lpage>1637</lpage>.</citation>
</ref>
<ref id="bibr5-0148607111416485">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rimm</surname><given-names>EB</given-names></name>
<name><surname>Willett</surname><given-names>WC</given-names></name>
<name><surname>Hu</surname><given-names>FB</given-names></name>
<etal/>
</person-group>. <article-title>Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women</article-title>. <source>JAMA</source>. <year>1998</year>;<volume>279</volume>:<fpage>359</fpage>-<lpage>364</lpage>.</citation>
</ref>
<ref id="bibr6-0148607111416485">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kirsh</surname><given-names>VA</given-names></name>
<name><surname>Hayes</surname><given-names>RB</given-names></name>
<name><surname>Mayne</surname><given-names>ST</given-names></name>
<etal/>
</person-group>. <article-title>Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk</article-title>. <source>J Natl Cancer Inst</source>. <year>2006</year>;<volume>98</volume>:<fpage>245</fpage>-<lpage>254</lpage>.</citation>
</ref>
<ref id="bibr7-0148607111416485">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>SM</given-names></name>
<name><surname>Moore</surname><given-names>SC</given-names></name>
<name><surname>Lin</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women</article-title>. <source>Am J Epidemiol</source>. <year>2006</year>;<volume>163</volume>:<fpage>108</fpage>-<lpage>115</lpage>.</citation>
</ref>
<ref id="bibr8-0148607111416485">
<label>8.</label>
<citation citation-type="book">
<collab>World Cancer Research Fund</collab>. <source>Food, Nutrition and the Prevention of Cancer: A Global Perspective</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Institute for Cancer Research</publisher-name>; <year>1997</year>.</citation>
</ref>
<ref id="bibr9-0148607111416485">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jakobisiak</surname><given-names>M</given-names></name>
<name><surname>Lasek</surname><given-names>W</given-names></name>
<name><surname>Golab</surname><given-names>J</given-names></name>
</person-group>. <article-title>Natural mechanisms protecting against cancer</article-title>. <source>Immunol Lett</source>. <year>2003</year>;<volume>90</volume>:<fpage>103</fpage>-<lpage>122</lpage>.</citation>
</ref>
<ref id="bibr10-0148607111416485">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blount</surname><given-names>BC</given-names></name>
<name><surname>Mack</surname><given-names>MM</given-names></name>
<name><surname>Wehr</surname><given-names>CM</given-names></name>
<etal/>
</person-group>. <article-title>Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1997</year>;<volume>94</volume>:<fpage>3290</fpage>-<lpage>3295</lpage>.</citation>
</ref>
<ref id="bibr11-0148607111416485">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ames</surname><given-names>BN</given-names></name>
</person-group>. <article-title>DNA damage from micronutrient deficiencies is likely to be a major cause of cancer</article-title>. <source>Mutat Res</source>. <year>2001</year>;<volume>475</volume>:<fpage>7</fpage>-<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr12-0148607111416485">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Radimer</surname><given-names>K</given-names></name>
<name><surname>Bindewald</surname><given-names>B</given-names></name>
<name><surname>Hughes</surname><given-names>J</given-names></name>
<name><surname>Ervin</surname><given-names>B</given-names></name>
<name><surname>Swanson</surname><given-names>C</given-names></name>
<name><surname>Picciano</surname><given-names>MF</given-names></name>
</person-group>. <article-title>Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000</article-title>. <source>Am J Epidemiol</source>. <year>2004</year>;<volume>160</volume>:<fpage>339</fpage>-<lpage>349</lpage>.</citation>
</ref>
<ref id="bibr13-0148607111416485">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Foote</surname><given-names>JA</given-names></name>
<name><surname>Murphy</surname><given-names>SP</given-names></name>
<name><surname>Wilkens</surname><given-names>LR</given-names></name>
<name><surname>Hankin</surname><given-names>JH</given-names></name>
<name><surname>Henderson</surname><given-names>BE</given-names></name>
<name><surname>Kolonel</surname><given-names>LN</given-names></name>
</person-group>. <article-title>Factors associated with dietary supplement use among healthy adults of five ethnicities: the Multiethnic Cohort Study</article-title>. <source>Am J Epidemiol</source>. <year>2003</year>;<volume>157</volume>:<fpage>888</fpage>-<lpage>897</lpage>.</citation>
</ref>
<ref id="bibr14-0148607111416485">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Archer</surname><given-names>SL</given-names></name>
<name><surname>Stamler</surname><given-names>J</given-names></name>
<name><surname>Moag-Stahlberg</surname><given-names>A</given-names></name>
<etal/>
</person-group>. <article-title>Association of dietary supplement use with specific micronutrient intakes among middle-aged American men and women: the INTERMAP Study</article-title>. <source>J Am Diet Assoc</source>. <year>2005</year>;<volume>105</volume>:<fpage>1106</fpage>-<lpage>1114</lpage>.</citation>
</ref>
<ref id="bibr15-0148607111416485">
<label>15.</label>
<citation citation-type="web">
<article-title>Supplements stand out as 2008 sales bright spot for U.S. nutrition industry</article-title>. <source>Nutrition Business Journal</source>. <year>2010</year>. <comment><ext-link ext-link-type="uri" xlink:href="http://nutritionbusinessjournal.com">http://nutritionbusinessjournal.com</ext-link></comment></citation>
</ref>
<ref id="bibr16-0148607111416485">
<label>16.</label>
<citation citation-type="web">
<collab>Natural Foods Merchandiser</collab>. <article-title>Vitamins and supplements</article-title>. <comment><ext-link ext-link-type="uri" xlink:href="http://www.naturalfoodmerchandiser.com">www.naturalfoodmerchandiser.com</ext-link></comment></citation>
</ref>
<ref id="bibr17-0148607111416485">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Morrow</surname><given-names>JD</given-names></name>
</person-group>. <article-title>Why the United States still needs improved dietary supplement regulation and oversight</article-title>. <source>Clin Pharmacol Ther</source>. <year>2008</year>;<volume>83</volume>:<fpage>391</fpage>-<lpage>393</lpage>.</citation>
</ref>
<ref id="bibr18-0148607111416485">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ford</surname><given-names>ES</given-names></name>
<name><surname>Ajani</surname><given-names>UA</given-names></name>
<name><surname>Mokdad</surname><given-names>AH</given-names></name>
</person-group>. <article-title>Brief communication: the prevalence of high intake of vitamin E from the use of supplements among U.S. adults</article-title>. <source>Ann Intern Med</source>. <year>2005</year>;<volume>143</volume>:<fpage>116</fpage>-<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr19-0148607111416485">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ko</surname><given-names>R</given-names></name>
</person-group>. <article-title>Safety of ethnic &amp; imported herbal and dietary supplements</article-title>. <source>Clin Toxicol</source>. <year>2006</year>;<volume>44</volume>:<fpage>611</fpage>-<lpage>616</lpage>.</citation>
</ref>
<ref id="bibr20-0148607111416485">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cohen</surname><given-names>PA</given-names></name>
</person-group>. <article-title>American roulette—contaminated dietary supplements</article-title>. <source>N Engl J Med</source>. <year>2009</year>;<volume>361</volume>:<fpage>1523</fpage>-<lpage>1525</lpage>.</citation>
</ref>
<ref id="bibr21-0148607111416485">
<label>21.</label>
<citation citation-type="web">
<collab>World Health Organization (WHO)</collab>. <article-title>Global prevalence of vitamin A deficiency in populations at risk 1995-2005</article-title>. <source>WHO Global Database on Vitamin A deficiency</source>. <year>2009</year>. <comment><ext-link ext-link-type="uri" xlink:href="http://whqlibdoc.who.int/publications/2009/9789241598019_eng.pdf">http://whqlibdoc.who.int/publications/2009/9789241598019_eng.pdf</ext-link></comment>. <access-date>Accessed May 11, 2011</access-date>.</citation>
</ref>
<ref id="bibr22-0148607111416485">
<label>22.</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>de Benoist</surname><given-names>B</given-names></name>
<name><surname>McLean</surname><given-names>E</given-names></name>
<name><surname>Egli</surname><given-names>I</given-names></name>
<name><surname>Cogswell</surname><given-names>M</given-names></name>
</person-group>. <article-title>Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia</article-title>. <year>2008</year>. <comment><ext-link ext-link-type="uri" xlink:href="http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf">http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf</ext-link></comment>. <access-date>Accessed May 11, 2011</access-date>.</citation>
</ref>
<ref id="bibr23-0148607111416485">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rahmathullah</surname><given-names>L</given-names></name>
<name><surname>Underwood</surname><given-names>BA</given-names></name>
<name><surname>Thulasiraj</surname><given-names>RD</given-names></name>
<name><surname>Milton</surname><given-names>RC</given-names></name>
<name><surname>Ramaswamy</surname><given-names>K</given-names></name>
</person-group>. <article-title>Reduced mortality among children in southern India receiving a small weekly dose of vitamin A</article-title>. <source>N Engl J Med</source>. <year>1990</year>;<volume>323</volume>:<fpage>929</fpage>-<lpage>935</lpage>.</citation>
</ref>
<ref id="bibr24-0148607111416485">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fawzi</surname><given-names>WW</given-names></name>
<name><surname>Chalmers</surname><given-names>TC</given-names></name>
<name><surname>Herrera</surname><given-names>MG</given-names></name>
<name><surname>Mosteller</surname><given-names>F</given-names></name>
</person-group>. <article-title>Vitamin A supplementation and child mortality: a meta-analysis</article-title>. <source>JAMA</source>. <year>1993</year>;<volume>269</volume>:<fpage>898</fpage>-<lpage>903</lpage>.</citation>
</ref>
<ref id="bibr25-0148607111416485">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>West</surname><given-names>KP</given-names><suffix>Jr</suffix></name>
<name><surname>Pokhrel</surname><given-names>RP</given-names></name>
<name><surname>Katz</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Efficacy of vitamin A in reducing preschool child mortality in Nepal</article-title>. <source>Lancet</source>. <year>1991</year>;<volume>338</volume>:<fpage>67</fpage>-<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr26-0148607111416485">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rotondi</surname><given-names>MA</given-names></name>
<name><surname>Khobzi</surname><given-names>N</given-names></name>
</person-group>. <article-title>Vitamin A supplementation and neonatal mortality in the developing world: a meta-regression of cluster-randomized trials</article-title>. <source>Bull World Health Organ</source>. <year>2010</year>;<volume>88</volume>:<fpage>697</fpage>-<lpage>702</lpage>.</citation>
</ref>
<ref id="bibr27-0148607111416485">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Black</surname><given-names>RE</given-names></name>
<name><surname>Allen</surname><given-names>LH</given-names></name>
<name><surname>Bhutta</surname><given-names>ZA</given-names></name>
<etal/>
</person-group>. <article-title>Maternal and child undernutrition: global and regional exposures and health consequences</article-title>. <source>Lancet</source>. <year>2008</year>;<volume>371</volume>:<fpage>243</fpage>-<lpage>260</lpage>.</citation>
</ref>
<ref id="bibr28-0148607111416485">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Willett</surname><given-names>WC</given-names></name>
<name><surname>Stampfer</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>Clinical practice: what vitamins should I be taking, doctor?</article-title> <source>N Engl J Med</source>. <year>2001</year>;<volume>345</volume>:<fpage>1819</fpage>-<lpage>1824</lpage>.</citation>
</ref>
<ref id="bibr29-0148607111416485">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Biau</surname><given-names>DJ</given-names></name>
<name><surname>Kerneis</surname><given-names>S</given-names></name>
<name><surname>Porcher</surname><given-names>R</given-names></name>
</person-group>. <article-title>Statistics in brief: the importance of sample size in the planning and interpretation of medical research</article-title>. <source>Clin Orthop Relat Res</source>. <year>2008</year>;<volume>466</volume>:<fpage>2282</fpage>-<lpage>2288</lpage>.</citation>
</ref>
<ref id="bibr30-0148607111416485">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moher</surname><given-names>D</given-names></name>
<name><surname>Cook</surname><given-names>DJ</given-names></name>
<name><surname>Eastwood</surname><given-names>S</given-names></name>
<name><surname>Olkin</surname><given-names>I</given-names></name>
<name><surname>Rennie</surname><given-names>D</given-names></name>
<name><surname>Stroup</surname><given-names>DF</given-names></name>
</person-group>. <article-title>Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses</article-title>. <source>Lancet</source>. <year>1999</year>;<volume>354</volume>:<fpage>1896</fpage>-<lpage>1900</lpage>.</citation>
</ref>
<ref id="bibr31-0148607111416485">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bjelakovic</surname><given-names>G</given-names></name>
<name><surname>Nikolova</surname><given-names>D</given-names></name>
<name><surname>Gluud</surname><given-names>LL</given-names></name>
<name><surname>Simonetti</surname><given-names>RG</given-names></name>
<name><surname>Gluud</surname><given-names>C</given-names></name>
</person-group>. <article-title>Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis</article-title>. <source>JAMA</source>. <year>2007</year>;<volume>297</volume>:<fpage>842</fpage>-<lpage>857</lpage>.</citation>
</ref>
<ref id="bibr32-0148607111416485">
<label>32.</label>
<citation citation-type="web">
<article-title>Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Insitute of Medicine</article-title>. <source>Dietary Reference Intakes for Calicum and Vitamin D</source>. <publisher-loc>Washington, DC</publisher-loc>, <publisher-name>National Academy Press</publisher-name>; <year>2010</year>. <comment><ext-link ext-link-type="uri" xlink:href="http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D.aspx">http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D.aspx</ext-link></comment></citation>
</ref>
<ref id="bibr33-0148607111416485">
<label>33.</label>
<citation citation-type="gov">
<person-group person-group-type="author">
<name><surname>Looker</surname><given-names>AC</given-names></name>
<name><surname>Johnson</surname><given-names>CL</given-names></name>
<name><surname>Lacher</surname><given-names>DA</given-names></name>
<name><surname>Pfeiffer</surname><given-names>CM</given-names></name>
<name><surname>Schleicher</surname><given-names>RL</given-names></name>
<name><surname>Sempos</surname><given-names>CT</given-names></name>
</person-group>. <article-title>Vitamin D status: United States, 2001-2006</article-title>. <comment>NCHS Data Brief No 59. <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/nchs/data/databriefs/db59.pdf">http://www.cdc.gov/nchs/data/databriefs/db59.pdf</ext-link></comment>. <access-date>Accessed May 10, 2011</access-date>.</citation>
</ref>
<ref id="bibr34-0148607111416485">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bischoff-Ferrari</surname><given-names>HA</given-names></name>
<name><surname>Dawson-Hughes</surname><given-names>B</given-names></name>
<name><surname>Willett</surname><given-names>WC</given-names></name>
<etal/>
</person-group>. <article-title>Effect of Vitamin D on falls: a meta-analysis</article-title>. <source>JAMA</source>. <year>2004</year>;<volume>291</volume>:<fpage>1999</fpage>-<lpage>2006</lpage>.</citation>
</ref>
<ref id="bibr35-0148607111416485">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Autier</surname><given-names>P</given-names></name>
<name><surname>Gandini</surname><given-names>S</given-names></name>
</person-group>. <article-title>Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials</article-title>. <source>Arch Intern Med</source>. <year>2007</year>;<volume>167</volume>:<fpage>1730</fpage>-<lpage>1737</lpage>.</citation>
</ref>
<ref id="bibr36-0148607111416485">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bischoff-Ferrari</surname><given-names>HA</given-names></name>
<name><surname>Willett</surname><given-names>WC</given-names></name>
<name><surname>Wong</surname><given-names>JB</given-names></name>
<name><surname>Giovannucci</surname><given-names>E</given-names></name>
<name><surname>Dietrich</surname><given-names>T</given-names></name>
<name><surname>Dawson-Hughes</surname><given-names>B</given-names></name>
</person-group>. <article-title>Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials</article-title>. <source>JAMA</source>. <year>2005</year>;<volume>293</volume>:<fpage>2257</fpage>-<lpage>2264</lpage>.</citation>
</ref>
<ref id="bibr37-0148607111416485">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bolland</surname><given-names>MJ</given-names></name>
<name><surname>Avenell</surname><given-names>A</given-names></name>
<name><surname>Baron</surname><given-names>JA</given-names></name>
<etal/>
</person-group>. <article-title>Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis</article-title>. <source>BMJ</source>. <year>2010</year>;<volume>341</volume>:<fpage>c3691</fpage>.</citation>
</ref>
<ref id="bibr38-0148607111416485">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dawson-Hughes</surname><given-names>B</given-names></name>
<name><surname>Mithal</surname><given-names>A</given-names></name>
<name><surname>Bonjour</surname><given-names>JP</given-names></name>
<etal/>
</person-group>. <article-title>IOF position statement: vitamin D recommendations for older adults</article-title>. <source>Osteoporosis Int</source>. <year>2010</year>;<volume>21</volume>:<fpage>1151</fpage>-<lpage>1154</lpage>.</citation>
</ref>
<ref id="bibr39-0148607111416485">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Holick</surname><given-names>MF</given-names></name>
</person-group>. <article-title>Vitamin D deficiency</article-title>. <source>N Engl J Med</source>. <year>2007</year>;<volume>357</volume>:<fpage>266</fpage>-<lpage>281</lpage>.</citation>
</ref>
<ref id="bibr40-0148607111416485">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kennel</surname><given-names>KA</given-names></name>
<name><surname>Drake</surname><given-names>MT</given-names></name>
<name><surname>Hurley</surname><given-names>DL</given-names></name>
</person-group>. <article-title>Vitamin D deficiency in adults: when to test and how to treat</article-title>. <source>Mayo Clin Proc</source>. <year>2010</year>;<volume>85</volume>:<fpage>752</fpage>-<lpage>758</lpage>.</citation>
</ref>
<ref id="bibr41-0148607111416485">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rosen</surname><given-names>CJ</given-names></name>
</person-group>. <article-title>Vitamin D insufficiency</article-title>. <source>N Engl J Med</source>. <year>2011</year>;<volume>364</volume>:<fpage>248</fpage>-<lpage>254</lpage>.</citation>
</ref>
<ref id="bibr42-0148607111416485">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tuomilehto</surname><given-names>J</given-names></name>
<name><surname>Lindstrom</surname><given-names>J</given-names></name>
<name><surname>Eriksson</surname><given-names>JG</given-names></name>
<etal/>
</person-group>. <article-title>Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance</article-title>. <source>N Engl J Med</source>. <year>2001</year>;<volume>344</volume>:<fpage>1343</fpage>-<lpage>1350</lpage>.</citation>
</ref>
<ref id="bibr43-0148607111416485">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Salas-Salvado</surname><given-names>J</given-names></name>
<name><surname>Fernandez-Ballart</surname><given-names>J</given-names></name>
<name><surname>Ros</surname><given-names>E</given-names></name>
<etal/>
</person-group>. <article-title>Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial</article-title>. <source>Arch Intern Med</source>. <year>2008</year>;<volume>168</volume>:<fpage>2449</fpage>-<lpage>2458</lpage>.</citation>
</ref>
<ref id="bibr44-0148607111416485">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Esposito</surname><given-names>K</given-names></name>
<name><surname>Maiorino</surname><given-names>MI</given-names></name>
<name><surname>Ciotola</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial</article-title>. <source>Ann Intern Med</source>. <year>2009</year>;<volume>151</volume>:<fpage>306</fpage>-<lpage>314</lpage>.</citation>
</ref>
<ref id="bibr45-0148607111416485">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Appel</surname><given-names>LJ</given-names></name>
<name><surname>Moore</surname><given-names>TJ</given-names></name>
<name><surname>Obarzanek</surname><given-names>E</given-names></name>
<etal/>
</person-group>. <article-title>A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group</article-title>. <source>N Engl J Med</source>. <year>1997</year>;<volume>336</volume>:<fpage>1117</fpage>-<lpage>1124</lpage>.</citation>
</ref>
<ref id="bibr46-0148607111416485">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Azadbakht</surname><given-names>L</given-names></name>
<name><surname>Mirmiran</surname><given-names>P</given-names></name>
<name><surname>Esmaillzadeh</surname><given-names>A</given-names></name>
<name><surname>Azizi</surname><given-names>T</given-names></name>
<name><surname>Azizi</surname><given-names>F</given-names></name>
</person-group>. <article-title>Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome</article-title>. <source>Diabetes Care</source>. <year>2005</year>;<volume>28</volume>:<fpage>2823</fpage>-<lpage>2831</lpage>.</citation>
</ref>
<ref id="bibr47-0148607111416485">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Knowler</surname><given-names>WC</given-names></name>
<name><surname>Barrett-Connor</surname><given-names>E</given-names></name>
<name><surname>Fowler</surname><given-names>SE</given-names></name>
<etal/>
</person-group>. <article-title>Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin</article-title>. <source>N Engl J Med</source>. <year>2002</year>;<volume>346</volume>:<fpage>393</fpage>-<lpage>403</lpage>.</citation>
</ref>
<ref id="bibr48-0148607111416485">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marik</surname><given-names>PE</given-names></name>
<name><surname>Corwin</surname><given-names>HL</given-names></name>
</person-group>. <article-title>Efficacy of RBC transfusion in the critically ill: a systematic review of the literature</article-title>. <source>Crit Care Med</source>. <year>2008</year>;<volume>36</volume>:<fpage>2667</fpage>-<lpage>2674</lpage>.</citation>
</ref>
<ref id="bibr49-0148607111416485">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Greenberg</surname><given-names>ER</given-names></name>
<name><surname>Baron</surname><given-names>JA</given-names></name>
<name><surname>Stukel</surname><given-names>TA</given-names></name>
<etal/>
</person-group>. <article-title>A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group</article-title>. <source>N Engl J Med</source>. <year>1990</year>;<volume>323</volume>:<fpage>789</fpage>-<lpage>795</lpage>.</citation>
</ref>
<ref id="bibr50-0148607111416485">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Green</surname><given-names>A</given-names></name>
<name><surname>Williams</surname><given-names>G</given-names></name>
<name><surname>Neale</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial</article-title>. <source>Lancet</source>. <year>1999</year>;<volume>354</volume>:<fpage>723</fpage>-<lpage>729</lpage>.</citation>
</ref>
<ref id="bibr51-0148607111416485">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hennekens</surname><given-names>CH</given-names></name>
<name><surname>Buring</surname><given-names>JE</given-names></name>
<name><surname>Manson</surname><given-names>JE</given-names></name>
<etal/>
</person-group>. <article-title>Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease</article-title>. <source>N Engl J Med</source>. <year>1996</year>;<volume>334</volume>:<fpage>1145</fpage>-<lpage>1149</lpage>.</citation>
</ref>
<ref id="bibr52-0148607111416485">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>IM</given-names></name>
<name><surname>Cook</surname><given-names>NR</given-names></name>
<name><surname>Manson</surname><given-names>JE</given-names></name>
<name><surname>Buring</surname><given-names>JE</given-names></name>
<name><surname>Hennekens</surname><given-names>CH</given-names></name>
</person-group>. <article-title>Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women’s Health Study</article-title>. <source>J Natl Cancer Inst</source>. <year>1999</year>;<volume>91</volume>:<fpage>2102</fpage>-<lpage>2106</lpage>.</citation>
</ref>
<ref id="bibr53-0148607111416485">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Omenn</surname><given-names>GS</given-names></name>
<name><surname>Goodman</surname><given-names>GE</given-names></name>
<name><surname>Thornquist</surname><given-names>MD</given-names></name>
<etal/>
</person-group>. <article-title>Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease</article-title>. <source>N Engl J Med</source>. <year>1996</year>;<volume>334</volume>:<fpage>1150</fpage>-<lpage>1155</lpage>.</citation>
</ref>
<ref id="bibr54-0148607111416485">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stephens</surname><given-names>NG</given-names></name>
<name><surname>Parsons</surname><given-names>A</given-names></name>
<name><surname>Schofield</surname><given-names>PM</given-names></name>
<name><surname>Kelly</surname><given-names>F</given-names></name>
<name><surname>Cheeseman</surname><given-names>K</given-names></name>
<name><surname>Mitchinson</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)</article-title>. <source>Lancet</source>. <year>1996</year>;<volume>347</volume>:<fpage>781</fpage>-<lpage>786</lpage>.</citation>
</ref>
<ref id="bibr55-0148607111416485">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>IM</given-names></name>
<name><surname>Cook</surname><given-names>NR</given-names></name>
<name><surname>Gaziano</surname><given-names>JM</given-names></name>
<etal/>
</person-group>. <article-title>Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women’s Health Study: a randomized controlled trial</article-title>. <source>JAMA</source>. <year>2005</year>;<volume>294</volume>:<fpage>56</fpage>-<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr56-0148607111416485">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kang</surname><given-names>JH</given-names></name>
<name><surname>Cook</surname><given-names>N</given-names></name>
<name><surname>Manson</surname><given-names>J</given-names></name>
<name><surname>Buring</surname><given-names>JE</given-names></name>
<name><surname>Grodstein</surname><given-names>F</given-names></name>
</person-group>. <article-title>A randomized trial of vitamin E supplementation and cognitive function in women</article-title>. <source>Arch Intern Med</source>. <year>2006</year>;<volume>166</volume>:<fpage>2462</fpage>-<lpage>2468</lpage>.</citation>
</ref>
<ref id="bibr57-0148607111416485">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yusuf</surname><given-names>S</given-names></name>
<name><surname>Dagenais</surname><given-names>G</given-names></name>
<name><surname>Pogue</surname><given-names>J</given-names></name>
<name><surname>Bosch</surname><given-names>J</given-names></name>
<name><surname>Sleight</surname><given-names>P</given-names></name>
</person-group>. <article-title>Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators</article-title>. <source>N Engl J Med</source>. <year>2000</year>;<volume>342</volume>:<fpage>154</fpage>-<lpage>160</lpage>.</citation>
</ref>
<ref id="bibr58-0148607111416485">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>de Gaetano</surname><given-names>G</given-names></name>
</person-group>. <article-title>Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project</article-title>. <source>Lancet</source>. <year>2001</year>;<volume>357</volume>:<fpage>89</fpage>-<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr59-0148607111416485">
<label>59.</label>
<citation citation-type="journal">
<article-title>Effects of tocopherol and deprenyl on the progression of disability in early Parkinson’s disease. The Parkinson Study Group</article-title>. <source>N Engl J Med</source>. <year>1993</year>;<volume>328</volume>:<fpage>176</fpage>-<lpage>183</lpage>.</citation>
</ref>
<ref id="bibr60-0148607111416485">
<label>60.</label>
<citation citation-type="journal">
<article-title>Mortality in DATATOP: a multicenter trial in early Parkinson’s disease. Parkinson Study Group</article-title>. <source>Ann Neurol</source>. <year>1998</year>;<volume>43</volume>:<fpage>318</fpage>-<lpage>325</lpage>.</citation>
</ref>
<ref id="bibr61-0148607111416485">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hodis</surname><given-names>HN</given-names></name>
<name><surname>Mack</surname><given-names>WJ</given-names></name>
<name><surname>LaBree</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS)</article-title>. <source>Circulation</source>. <year>2002</year>;<volume>106</volume>:<fpage>1453</fpage>-<lpage>1459</lpage>.</citation>
</ref>
<ref id="bibr62-0148607111416485">
<label>62.</label>
<citation citation-type="journal">
<article-title>The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group</article-title>. <source>N Engl J Med</source>. <year>1994</year>;<volume>330</volume>:<fpage>1029</fpage>-<lpage>1035</lpage>.</citation>
</ref>
<ref id="bibr63-0148607111416485">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gaziano</surname><given-names>JM</given-names></name>
<name><surname>Glynn</surname><given-names>RJ</given-names></name>
<name><surname>Christen</surname><given-names>WG</given-names></name>
<etal/>
</person-group>. <article-title>Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians’ Health Study II randomized controlled trial</article-title>. <source>JAMA</source>. <year>2009</year>;<volume>301</volume>:<fpage>52</fpage>-<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr64-0148607111416485">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sesso</surname><given-names>HD</given-names></name>
<name><surname>Buring</surname><given-names>JE</given-names></name>
<name><surname>Christen</surname><given-names>WG</given-names></name>
<etal/>
</person-group>. <article-title>Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians’ Health Study II randomized controlled trial</article-title>. <source>JAMA</source>. <year>2008</year>;<volume>300</volume>:<fpage>2123</fpage>-<lpage>2133</lpage>.</citation>
</ref>
<ref id="bibr65-0148607111416485">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Waters</surname><given-names>DD</given-names></name>
<name><surname>Alderman</surname><given-names>EL</given-names></name>
<name><surname>Hsia</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial</article-title>. <source>JAMA</source>. <year>2002</year>;<volume>288</volume>:<fpage>2432</fpage>-<lpage>2440</lpage>.</citation>
</ref>
<ref id="bibr66-0148607111416485">
<label>66.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Greenberg</surname><given-names>ER</given-names></name>
<name><surname>Baron</surname><given-names>JA</given-names></name>
<name><surname>Tosteson</surname><given-names>TD</given-names></name>
<etal/>
</person-group>. <article-title>A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group</article-title>. <source>N Engl J Med</source>. <year>1994</year>;<volume>331</volume>:<fpage>141</fpage>-<lpage>147</lpage>.</citation>
</ref>
<ref id="bibr67-0148607111416485">
<label>67.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Song</surname><given-names>Y</given-names></name>
<name><surname>Cook</surname><given-names>NR</given-names></name>
<name><surname>Albert</surname><given-names>CM</given-names></name>
<name><surname>Van</surname><given-names>DM</given-names></name>
<name><surname>Manson</surname><given-names>JE</given-names></name>
</person-group>. <article-title>Effects of vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial</article-title>. <source>Am J Clin Nutr</source>. <year>2009</year>;<volume>90</volume>:<fpage>429</fpage>-<lpage>437</lpage>.</citation>
</ref>
<ref id="bibr68-0148607111416485">
<label>68.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cook</surname><given-names>NR</given-names></name>
<name><surname>Albert</surname><given-names>CM</given-names></name>
<name><surname>Gaziano</surname><given-names>JM</given-names></name>
<etal/>
</person-group>. <article-title>A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women’s Antioxidant Cardiovascular Study</article-title>. <source>Arch Intern Med</source>. <year>2007</year>;<volume>167</volume>:<fpage>1610</fpage>-<lpage>1618</lpage>.</citation>
</ref>
<ref id="bibr69-0148607111416485">
<label>69.</label>
<citation citation-type="journal">
<article-title>MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial</article-title>. <source>Lancet</source>. <year>2002</year>;<volume>360</volume>:<fpage>23</fpage>-<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr70-0148607111416485">
<label>70.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lippman</surname><given-names>SM</given-names></name>
<name><surname>Klein</surname><given-names>EA</given-names></name>
<name><surname>Goodman</surname><given-names>PJ</given-names></name>
<etal/>
</person-group>. <article-title>Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)</article-title>. <source>JAMA</source>. <year>2009</year>;<volume>301</volume>:<fpage>39</fpage>-<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr71-0148607111416485">
<label>71.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hercberg</surname><given-names>S</given-names></name>
<name><surname>Galan</surname><given-names>P</given-names></name>
<name><surname>Preziosi</surname><given-names>P</given-names></name>
<etal/>
</person-group>. <article-title>The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals</article-title>. <source>Arch Intern Med</source>. <year>2004</year>;<volume>164</volume>:<fpage>2335</fpage>-<lpage>2342</lpage>.</citation>
</ref>
<ref id="bibr72-0148607111416485">
<label>72.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Graat</surname><given-names>JM</given-names></name>
<name><surname>Schouten</surname><given-names>EG</given-names></name>
<name><surname>Kok</surname><given-names>FJ</given-names></name>
</person-group>. <article-title>Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial</article-title>. <source>JAMA</source>. <year>2002</year>;<volume>288</volume>:<fpage>715</fpage>-<lpage>721</lpage>.</citation>
</ref>
<ref id="bibr73-0148607111416485">
<label>73.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McNeil</surname><given-names>JJ</given-names></name>
<name><surname>Robman</surname><given-names>L</given-names></name>
<name><surname>Tikellis</surname><given-names>G</given-names></name>
<name><surname>Sinclair</surname><given-names>MI</given-names></name>
<name><surname>McCarty</surname><given-names>CA</given-names></name>
<name><surname>Taylor</surname><given-names>HR</given-names></name>
</person-group>. <article-title>Vitamin E supplementation and cataract: randomized controlled trial</article-title>. <source>Ophthalmology</source>. <year>2004</year>;<volume>111</volume>:<fpage>75</fpage>-<lpage>84</lpage>.</citation>
</ref>
<ref id="bibr74-0148607111416485">
<label>74.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chylack</surname><given-names>LT</given-names><suffix>Jr.</suffix></name>
<name><surname>Brown</surname><given-names>NP</given-names></name>
<name><surname>Bron</surname><given-names>A</given-names></name>
<etal/>
</person-group>. <article-title>The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract</article-title>. <source>Ophthalmic Epidemiol</source>. <year>2002</year>;<volume>9</volume>:<fpage>49</fpage>-<lpage>80</lpage>.</citation>
</ref>
<ref id="bibr75-0148607111416485">
<label>75.</label>
<citation citation-type="journal">
<article-title>A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9</article-title>. <source>Arch Opthal</source>. <year>2001</year>;<volume>119</volume>:<fpage>1439</fpage>-<lpage>1452</lpage>.</citation>
</ref>
<ref id="bibr76-0148607111416485">
<label>76.</label>
<citation citation-type="journal">
<article-title>A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8</article-title>. <source>Arch Opthal</source>. <year>2001</year>;<volume>119</volume>:<fpage>1417</fpage>-<lpage>1436</lpage>.</citation>
</ref>
<ref id="bibr77-0148607111416485">
<label>77.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>K</given-names></name>
<name><surname>Platz</surname><given-names>EA</given-names></name>
<name><surname>Willett</surname><given-names>WC</given-names></name>
<etal/>
</person-group>. <article-title>A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma</article-title>. <source>Am J Clin Nutr</source>. <year>2009</year>;<volume>90</volume>:<fpage>1623</fpage>-<lpage>1631</lpage>.</citation>
</ref>
<ref id="bibr78-0148607111416485">
<label>78.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Logan</surname><given-names>RF</given-names></name>
<name><surname>Grainge</surname><given-names>MJ</given-names></name>
<name><surname>Shepherd</surname><given-names>VC</given-names></name>
<name><surname>Armitage</surname><given-names>NC</given-names></name>
<name><surname>Muir</surname><given-names>KR</given-names></name>
</person-group>. <article-title>Aspirin and folic acid for the prevention of recurrent colorectal adenomas</article-title>. <source>Gastroenterology</source>. <year>2008</year>;<volume>134</volume>:<fpage>29</fpage>-<lpage>38</lpage>.</citation>
</ref>
<ref id="bibr79-0148607111416485">
<label>79.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cole</surname><given-names>BF</given-names></name>
<name><surname>Baron</surname><given-names>JA</given-names></name>
<name><surname>Sandler</surname><given-names>RS</given-names></name>
<etal/>
</person-group>. <article-title>Folic acid for the prevention of colorectal adenomas: a randomized clinical trial</article-title>. <source>JAMA</source>. <year>2007</year>;<volume>297</volume>:<fpage>2351</fpage>-<lpage>2359</lpage>.</citation>
</ref>
<ref id="bibr80-0148607111416485">
<label>80.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Durga</surname><given-names>J</given-names></name>
<name><surname>van Boxtel</surname><given-names>MP</given-names></name>
<name><surname>Schouten</surname><given-names>EG</given-names></name>
<etal/>
</person-group>. <article-title>Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial</article-title>. <source>Lancet</source>. <year>2007</year>;<volume>369</volume>:<fpage>208</fpage>-<lpage>216</lpage>.</citation>
</ref>
<ref id="bibr81-0148607111416485">
<label>81.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Armitage</surname><given-names>JM</given-names></name>
<name><surname>Bowman</surname><given-names>L</given-names></name>
<name><surname>Clarke</surname><given-names>RJ</given-names></name>
<etal/>
</person-group>. <article-title>Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial</article-title>. <source>JAMA</source>. <year>2010</year>;<volume>303</volume>:<fpage>2486</fpage>-<lpage>2494</lpage>.</citation>
</ref>
<ref id="bibr82-0148607111416485">
<label>82.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>SM</given-names></name>
<name><surname>Cook</surname><given-names>NR</given-names></name>
<name><surname>Albert</surname><given-names>CM</given-names></name>
<name><surname>Gaziano</surname><given-names>JM</given-names></name>
<name><surname>Buring</surname><given-names>JE</given-names></name>
<name><surname>Manson</surname><given-names>JE</given-names></name>
</person-group>. <article-title>Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial</article-title>. <source>JAMA</source>. <year>2008</year>;<volume>300</volume>:<fpage>2012</fpage>-<lpage>2021</lpage>.</citation>
</ref>
<ref id="bibr83-0148607111416485">
<label>83.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Albert</surname><given-names>CM</given-names></name>
<name><surname>Cook</surname><given-names>NR</given-names></name>
<name><surname>Gaziano</surname><given-names>JM</given-names></name>
<etal/>
</person-group>. <article-title>Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial</article-title>. <source>JAMA</source>. <year>2008</year>;<volume>299</volume>:<fpage>2027</fpage>-<lpage>2036</lpage>.</citation>
</ref>
<ref id="bibr84-0148607111416485">
<label>84.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Christen</surname><given-names>WG</given-names></name>
<name><surname>Glynn</surname><given-names>RJ</given-names></name>
<name><surname>Chew</surname><given-names>EY</given-names></name>
<name><surname>Albert</surname><given-names>CM</given-names></name>
<name><surname>Manson</surname><given-names>JE</given-names></name>
</person-group>. <article-title>Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women’s Antioxidant and Folic Acid Cardiovascular Study</article-title>. <source>Arch Intern Med</source>. <year>2009</year>;<volume>169</volume>:<fpage>335</fpage>-<lpage>341</lpage>.</citation>
</ref>
<ref id="bibr85-0148607111416485">
<label>85.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aisen</surname><given-names>PS</given-names></name>
<name><surname>Schneider</surname><given-names>LS</given-names></name>
<name><surname>Sano</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial</article-title>. <source>JAMA</source>. <year>2008</year>;<volume>300</volume>:<fpage>1774</fpage>-<lpage>1783</lpage>.</citation>
</ref>
<ref id="bibr86-0148607111416485">
<label>86.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ebbing</surname><given-names>M</given-names></name>
<name><surname>Bleie</surname><given-names>O</given-names></name>
<name><surname>Ueland</surname><given-names>PM</given-names></name>
<etal/>
</person-group>. <article-title>Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial</article-title>. <source>JAMA</source>. <year>2008</year>;<volume>300</volume>:<fpage>795</fpage>-<lpage>804</lpage>.</citation>
</ref>
<ref id="bibr87-0148607111416485">
<label>87.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bonaa</surname><given-names>KH</given-names></name>
<name><surname>Njolstad</surname><given-names>I</given-names></name>
<name><surname>Ueland</surname><given-names>PM</given-names></name>
<etal/>
</person-group>. <article-title>Homocysteine lowering and cardiovascular events after acute myocardial infarction</article-title>. <source>N Engl J Med</source>. <year>2006</year>;<volume>354</volume>:<fpage>1578</fpage>-<lpage>1588</lpage>.</citation>
</ref>
<ref id="bibr88-0148607111416485">
<label>88.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ebbing</surname><given-names>M</given-names></name>
<name><surname>Bonaa</surname><given-names>KH</given-names></name>
<name><surname>Nygard</surname><given-names>O</given-names></name>
<etal/>
</person-group>. <article-title>Cancer incidence and mortality after treatment with folic acid and vitamin B12</article-title>. <source>JAMA</source>. <year>2009</year>;<volume>302</volume>:<fpage>2119</fpage>-<lpage>2126</lpage>.</citation>
</ref>
<ref id="bibr89-0148607111416485">
<label>89.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lonn</surname><given-names>E</given-names></name>
<name><surname>Yusuf</surname><given-names>S</given-names></name>
<name><surname>Arnold</surname><given-names>MJ</given-names></name>
<etal/>
</person-group>. <article-title>Homocysteine lowering with folic acid and B vitamins in vascular disease</article-title>. <source>N Engl J Med</source>. <year>2006</year>;<volume>354</volume>:<fpage>1567</fpage>-<lpage>1577</lpage>.</citation>
</ref>
<ref id="bibr90-0148607111416485">
<label>90.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McMahon</surname><given-names>JA</given-names></name>
<name><surname>Green</surname><given-names>TJ</given-names></name>
<name><surname>Skeaff</surname><given-names>CM</given-names></name>
<name><surname>Knight</surname><given-names>RG</given-names></name>
<name><surname>Mann</surname><given-names>JI</given-names></name>
<name><surname>Williams</surname><given-names>SM</given-names></name>
</person-group>. <article-title>A controlled trial of homocysteine lowering and cognitive performance</article-title>. <source>N Engl J Med</source>. <year>2006</year>;<volume>354</volume>:<fpage>2764</fpage>-<lpage>2772</lpage>.</citation>
</ref>
<ref id="bibr91-0148607111416485">
<label>91.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Toole</surname><given-names>JF</given-names></name>
<name><surname>Malinow</surname><given-names>MR</given-names></name>
<name><surname>Chambless</surname><given-names>LE</given-names></name>
<etal/>
</person-group>. <article-title>Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial</article-title>. <source>JAMA</source>. <year>2004</year>;<volume>291</volume>:<fpage>565</fpage>-<lpage>575</lpage>.</citation>
</ref>
<ref id="bibr92-0148607111416485">
<label>92.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>LaCroix</surname><given-names>AZ</given-names></name>
<name><surname>Kotchen</surname><given-names>J</given-names></name>
<name><surname>Anderson</surname><given-names>G</given-names></name>
<etal/>
</person-group>. <article-title>Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women’s Health Initiative calcium-vitamin D randomized controlled trial</article-title>. <source>J Gerontol</source>. <year>2009</year>;<volume>64</volume>:<fpage>559</fpage>-<lpage>567</lpage>.</citation>
</ref>
<ref id="bibr93-0148607111416485">
<label>93.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jackson</surname><given-names>RD</given-names></name>
<name><surname>LaCroix</surname><given-names>AZ</given-names></name>
<name><surname>Gass</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Calcium plus vitamin D supplementation and the risk of fractures</article-title>. <source>N Engl J Med</source>. <year>2006</year>;<volume>354</volume>:<fpage>669</fpage>-<lpage>683</lpage>.</citation>
</ref>
<ref id="bibr94-0148607111416485">
<label>94.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wactawski-Wende</surname><given-names>J</given-names></name>
<name><surname>Kotchen</surname><given-names>JM</given-names></name>
<name><surname>Anderson</surname><given-names>GL</given-names></name>
<etal/>
</person-group>. <article-title>Calcium plus vitamin D supplementation and the risk of colorectal cancer</article-title>. <source>N Engl J Med</source>. <year>2006</year>;<volume>354</volume>:<fpage>684</fpage>-<lpage>696</lpage>.</citation>
</ref>
<ref id="bibr95-0148607111416485">
<label>95.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hsia</surname><given-names>J</given-names></name>
<name><surname>Heiss</surname><given-names>G</given-names></name>
<name><surname>Ren</surname><given-names>H</given-names></name>
<etal/>
</person-group>. <article-title>Calcium/vitamin D supplementation and cardiovascular events</article-title>. <source>Circulation</source>. <year>2007</year>;<volume>115</volume>:<fpage>846</fpage>-<lpage>854</lpage>.</citation>
</ref>
<ref id="bibr96-0148607111416485">
<label>96.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Porthouse</surname><given-names>J</given-names></name>
<name><surname>Cockayne</surname><given-names>S</given-names></name>
<name><surname>King</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care</article-title>. <source>BMJ</source>. <year>2005</year>;<volume>330</volume>:<year>1003</year>.</citation>
</ref>
<ref id="bibr97-0148607111416485">
<label>97.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grant</surname><given-names>AM</given-names></name>
<name><surname>Avenell</surname><given-names>A</given-names></name>
<name><surname>Campbell</surname><given-names>MK</given-names></name>
<etal/>
</person-group>. <article-title>Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial</article-title>. <source>Lancet</source>. <year>2005</year>;<volume>365</volume>:<fpage>1621</fpage>-<lpage>1628</lpage>.</citation>
</ref>
<ref id="bibr98-0148607111416485">
<label>98.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dawson-Hughes</surname><given-names>B</given-names></name>
<name><surname>Harris</surname><given-names>SS</given-names></name>
<name><surname>Krall</surname><given-names>EA</given-names></name>
<name><surname>Dallal</surname><given-names>GE</given-names></name>
</person-group>. <article-title>Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older</article-title>. <source>N Engl J Med</source>. <year>1997</year>;<volume>337</volume>:<fpage>670</fpage>-<lpage>676</lpage>.</citation>
</ref>
<ref id="bibr99-0148607111416485">
<label>99.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chapuy</surname><given-names>MC</given-names></name>
<name><surname>Arlot</surname><given-names>ME</given-names></name>
<name><surname>Delmas</surname><given-names>PD</given-names></name>
<name><surname>Meunier</surname><given-names>PJ</given-names></name>
</person-group>. <article-title>Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women</article-title>. <source>BMJ</source>. <year>1994</year>;<volume>308</volume>:<fpage>1081</fpage>-<lpage>1082</lpage>.</citation>
</ref>
<ref id="bibr100-0148607111416485">
<label>100.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Prince</surname><given-names>RL</given-names></name>
<name><surname>Austin</surname><given-names>N</given-names></name>
<name><surname>Devine</surname><given-names>A</given-names></name>
<name><surname>Dick</surname><given-names>IM</given-names></name>
<name><surname>Bruce</surname><given-names>D</given-names></name>
<name><surname>Zhu</surname><given-names>K</given-names></name>
</person-group>. <article-title>Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women</article-title>. <source>Arch Intern Med</source>. <year>2008</year>;<volume>168</volume>:<fpage>103</fpage>-<lpage>108</lpage>.</citation>
</ref>
<ref id="bibr101-0148607111416485">
<label>101.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lappe</surname><given-names>JM</given-names></name>
<name><surname>Travers-Gustafson</surname><given-names>D</given-names></name>
<name><surname>Davies</surname><given-names>KM</given-names></name>
<name><surname>Recker</surname><given-names>RR</given-names></name>
<name><surname>Heaney</surname><given-names>RP</given-names></name>
</person-group>. <article-title>Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial</article-title>. <source>Am J Clin Nutr</source>. <year>2007</year>;<volume>85</volume>:<fpage>1586</fpage>-<lpage>1591</lpage>.</citation>
</ref>
<ref id="bibr102-0148607111416485">
<label>102.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Meyer</surname><given-names>HE</given-names></name>
<name><surname>Smedshaug</surname><given-names>GB</given-names></name>
<name><surname>Kvaavik</surname><given-names>E</given-names></name>
<name><surname>Falch</surname><given-names>JA</given-names></name>
<name><surname>Tverdal</surname><given-names>A</given-names></name>
<name><surname>Pedersen</surname><given-names>JI</given-names></name>
</person-group>. <article-title>Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial</article-title>. <source>J Bone Miner Res</source>. <year>2002</year>;<volume>17</volume>:<fpage>709</fpage>-<lpage>715</lpage>.</citation>
</ref>
<ref id="bibr103-0148607111416485">
<label>103.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lips</surname><given-names>P</given-names></name>
<name><surname>Graafmans</surname><given-names>WC</given-names></name>
<name><surname>Ooms</surname><given-names>ME</given-names></name>
<name><surname>Bezemer</surname><given-names>PD</given-names></name>
<name><surname>Bouter</surname><given-names>LM</given-names></name>
</person-group>. <article-title>Vitamin D supplementation and fracture incidence in elderly persons: a randomized, placebo-controlled clinical trial</article-title>. <source>Ann Intern Med</source>. <year>1996</year>;<volume>124</volume>:<fpage>400</fpage>-<lpage>406</lpage>.</citation>
</ref>
<ref id="bibr104-0148607111416485">
<label>104.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Trivedi</surname><given-names>DP</given-names></name>
<name><surname>Doll</surname><given-names>R</given-names></name>
<name><surname>Khaw</surname><given-names>KT</given-names></name>
</person-group>. <article-title>Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial</article-title>. <source>BMJ</source>. <year>2003</year>;<volume>326</volume>:<fpage>469</fpage>.</citation>
</ref>
<ref id="bibr105-0148607111416485">
<label>105.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gallagher</surname><given-names>JC</given-names></name>
<name><surname>Fowler</surname><given-names>SE</given-names></name>
<name><surname>Detter</surname><given-names>JR</given-names></name>
<name><surname>Sherman</surname><given-names>SS</given-names></name>
</person-group>. <article-title>Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2001</year>;<volume>86</volume>:<fpage>3618</fpage>-<lpage>3628</lpage>.</citation>
</ref>
<ref id="bibr106-0148607111416485">
<label>106.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Smith</surname><given-names>H</given-names></name>
<name><surname>Anderson</surname><given-names>F</given-names></name>
<name><surname>Raphael</surname><given-names>H</given-names></name>
<name><surname>Maslin</surname><given-names>P</given-names></name>
<name><surname>Crozier</surname><given-names>S</given-names></name>
<name><surname>Cooper</surname><given-names>C</given-names></name>
</person-group>. <article-title>Effect of annual intramuscular vitamin D on fracture risk in elderly men and women—a population-based, randomized, double-blind, placebo-controlled trial</article-title>. <source>Rheumatology</source>. <year>2007</year>;<volume>46</volume>:<fpage>1852</fpage>-<lpage>1857</lpage>.</citation>
</ref>
<ref id="bibr107-0148607111416485">
<label>107.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sanders</surname><given-names>KM</given-names></name>
<name><surname>Stuart</surname><given-names>AL</given-names></name>
<name><surname>Williamson</surname><given-names>EA</given-names></name>
<etal/>
</person-group>. <article-title>Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial</article-title>. <source>JAMA</source>. <year>2010</year>;<volume>303</volume>:<fpage>1815</fpage>-<lpage>1822</lpage>.</citation>
</ref>
<ref id="bibr108-0148607111416485">
<label>108.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Prince</surname><given-names>RL</given-names></name>
<name><surname>Devine</surname><given-names>A</given-names></name>
<name><surname>Dhaliwal</surname><given-names>SS</given-names></name>
<name><surname>Dick</surname><given-names>IM</given-names></name>
</person-group>. <article-title>Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women</article-title>. <source>Arch Intern Med</source>. <year>2006</year>;<volume>166</volume>:<fpage>869</fpage>-<lpage>875</lpage>.</citation>
</ref>
<ref id="bibr109-0148607111416485">
<label>109.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bolland</surname><given-names>MJ</given-names></name>
<name><surname>Barber</surname><given-names>PA</given-names></name>
<name><surname>Doughty</surname><given-names>RN</given-names></name>
<etal/>
</person-group>. <article-title>Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial</article-title>. <source>BMJ</source>. <year>2008</year>;<volume>336</volume>:<fpage>262</fpage>-<lpage>266</lpage>.</citation>
</ref>
<ref id="bibr110-0148607111416485">
<label>110.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bischoff-Ferrari</surname><given-names>HA</given-names></name>
<name><surname>Rees</surname><given-names>JR</given-names></name>
<name><surname>Grau</surname><given-names>MV</given-names></name>
<name><surname>Barry</surname><given-names>E</given-names></name>
<name><surname>Gui</surname><given-names>J</given-names></name>
<name><surname>Baron</surname><given-names>JA</given-names></name>
</person-group>. <article-title>Effect of calcium supplementation on fracture risk: a double-blind randomized controlled trial</article-title>. <source>Am J Clin Nutr</source>. <year>2008</year>;<volume>87</volume>:<fpage>1945</fpage>-<lpage>1951</lpage>.</citation>
</ref>
<ref id="bibr111-0148607111416485">
<label>111.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Baron</surname><given-names>JA</given-names></name>
<name><surname>Beach</surname><given-names>M</given-names></name>
<name><surname>Mandel</surname><given-names>JS</given-names></name>
<etal/>
</person-group>. <article-title>Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group</article-title>. <source>N Engl J Med</source>. <year>1999</year>;<volume>340</volume>:<fpage>101</fpage>-<lpage>107</lpage>.</citation>
</ref>
<ref id="bibr112-0148607111416485">
<label>112.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Clark</surname><given-names>LC</given-names></name>
<name><surname>Combs</surname><given-names>GF</given-names><suffix>Jr</suffix></name>
<name><surname>Turnbull</surname><given-names>BW</given-names></name>
<etal/>
</person-group>. <article-title>Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. Nutritional Prevention of Cancer Study Group</article-title>. <source>JAMA</source>. <year>1996</year>;<volume>276</volume>:<fpage>1957</fpage>-<lpage>1963</lpage>.</citation>
</ref>
<ref id="bibr113-0148607111416485">
<label>113.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stranges</surname><given-names>S</given-names></name>
<name><surname>Marshall</surname><given-names>JR</given-names></name>
<name><surname>Natarajan</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial</article-title>. <source>Ann Intern Med</source>. <year>2007</year>;<volume>147</volume>:<fpage>217</fpage>-<lpage>223</lpage>.</citation>
</ref>
<ref id="bibr114-0148607111416485">
<label>114.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stranges</surname><given-names>S</given-names></name>
<name><surname>Marshall</surname><given-names>JR</given-names></name>
<name><surname>Trevisan</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial</article-title>. <source>Am J Epidemiol</source>. <year>2006</year>;<volume>163</volume>:<fpage>694</fpage>-<lpage>699</lpage>.</citation>
</ref>
<ref id="bibr115-0148607111416485">
<label>115.</label>
<citation citation-type="journal">
<article-title>Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial</article-title>. <source>Lancet</source>. <year>1999</year>;<volume>354</volume>:<fpage>447</fpage>-<lpage>455</lpage>.</citation>
</ref>
<ref id="bibr116-0148607111416485">
<label>116.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yokoyama</surname><given-names>M</given-names></name>
<name><surname>Origasa</surname><given-names>H</given-names></name>
<name><surname>Matsuzaki</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis</article-title>. <source>Lancet</source>. <year>2007</year>;<volume>369</volume>:<fpage>1090</fpage>-<lpage>1098</lpage>.</citation>
</ref>
<ref id="bibr117-0148607111416485">
<label>117.</label>
<citation citation-type="journal">
<article-title>Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial</article-title>. <source>Lancet</source>. <year>2008</year>;<volume>372</volume>:<fpage>1223</fpage>-<lpage>1230</lpage>.</citation>
</ref>
<ref id="bibr118-0148607111416485">
<label>118.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dangour</surname><given-names>AD</given-names></name>
<name><surname>Allen</surname><given-names>E</given-names></name>
<name><surname>Elbourne</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial</article-title>. <source>Am J Clin Nutr</source>. <year>2010</year>;<volume>91</volume>:<fpage>1725</fpage>-<lpage>1732</lpage>.</citation>
</ref>
<ref id="bibr119-0148607111416485">
<label>119.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Quinn</surname><given-names>JF</given-names></name>
<name><surname>Raman</surname><given-names>R</given-names></name>
<name><surname>Thomas</surname><given-names>RG</given-names></name>
<etal/>
</person-group>. <article-title>Docosahexaenoic acid supplementation and cognitive decline in Alzheimers disease: a randomized trial</article-title>. <source>JAMA</source>. <year>2010</year>;<volume>304</volume>:<fpage>1903</fpage>-<lpage>1911</lpage>.</citation>
</ref>
<ref id="bibr120-0148607111416485">
<label>120.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Le Bars</surname><given-names>PL</given-names></name>
<name><surname>Katz</surname><given-names>MM</given-names></name>
<name><surname>Berman</surname><given-names>N</given-names></name>
<name><surname>Itil</surname><given-names>TM</given-names></name>
<name><surname>Freedman</surname><given-names>AM</given-names></name>
<name><surname>Schatzberg</surname><given-names>AF</given-names></name>
</person-group>. <article-title>A placebo-controlled, double-blind, randomized trial of an extract of <italic>Ginkgo biloba</italic> for dementia. North American EGb Study Group</article-title>. <source>JAMA</source>. <year>1997</year>;<volume>278</volume>:<fpage>1327</fpage>-<lpage>1332</lpage>.</citation>
</ref>
<ref id="bibr121-0148607111416485">
<label>121.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Snitz</surname><given-names>BE</given-names></name>
<name><surname>O’Meara</surname><given-names>ES</given-names></name>
<name><surname>Carlson</surname><given-names>MC</given-names></name>
<etal/>
</person-group>. <article-title><italic>Ginkgo biloba</italic> for preventing cognitive decline in older adults: a randomized trial</article-title>. <source>JAMA</source>. <year>2009</year>;<volume>302</volume>:<fpage>2663</fpage>-<lpage>2670</lpage>.</citation>
</ref>
<ref id="bibr122-0148607111416485">
<label>122.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuller</surname><given-names>LH</given-names></name>
<name><surname>Ives</surname><given-names>DG</given-names></name>
<name><surname>Fitzpatrick</surname><given-names>AL</given-names></name>
<etal/>
</person-group>. <article-title>Does <italic>Ginkgo biloba</italic> reduce the risk of cardiovascular events?</article-title> <source>Circulation</source>. <year>2010</year>;<volume>3</volume>:<fpage>41</fpage>-<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr123-0148607111416485">
<label>123.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wilkens</surname><given-names>P</given-names></name>
<name><surname>Scheel</surname><given-names>IB</given-names></name>
<name><surname>Grundnes</surname><given-names>O</given-names></name>
<name><surname>Hellum</surname><given-names>C</given-names></name>
<name><surname>Storheim</surname><given-names>K</given-names></name>
</person-group>. <article-title>Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: a randomized controlled trial</article-title>. <source>JAMA</source>. <year>2010</year>;<volume>304</volume>:<fpage>45</fpage>-<lpage>52</lpage>.</citation>
</ref>
<ref id="bibr124-0148607111416485">
<label>124.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bent</surname><given-names>S</given-names></name>
<name><surname>Kane</surname><given-names>C</given-names></name>
<name><surname>Shinohara</surname><given-names>K</given-names></name>
<etal/>
</person-group>. <article-title>Saw palmetto for benign prostatic hyperplasia</article-title>. <source>N Engl J Med</source>. <year>2006</year>;<volume>354</volume>:<fpage>557</fpage>-<lpage>566</lpage>.</citation>
</ref>
<ref id="bibr125-0148607111416485">
<label>125.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pares</surname><given-names>A</given-names></name>
<name><surname>Planas</surname><given-names>R</given-names></name>
<name><surname>Torres</surname><given-names>M</given-names></name>
<name><surname>Caballeria</surname><given-names>J</given-names></name>
<name><surname>Viver</surname><given-names>JM</given-names></name>
<name><surname>Acero</surname><given-names>D</given-names></name>
</person-group>. <article-title>Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial</article-title>. <source>J Hepatol</source>. <year>1998</year>;<volume>28</volume>:<fpage>615</fpage>-<lpage>621</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>